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Background: Obstructive Sleep Apnea (OSA) contributes to all-cause and cardiac mortality.
There are no current guidelines for OSA screening in outpatient settings. An American Academy
of Sleep Medicine task force is focusing on improving detection and categorization of OSA
symptoms and severity to promote screening, assessment, and diagnosis of the disorder. The
purpose of this study was to identify the psychometric properties of three self-report OSA
screening measures (Berlin, Epworth Sleepiness Scale (ESS), STOP Bang) and an objective
portable sleep monitor (PSM) compared to apnea-hypopnea index (AHI) levels (≥5, ≥ 15, and ≥
30) from polysomnogram (PSG).
Methods: A methodological design was used. Patients referred to a sleep specialist for an OSA
consultation were recruited and enrolled at initial sleep evaluation. Participants completed the
three OSA self-report screening measures and those participants who met inclusion criteria were
sent home with a PSM for one night measurement. Automatic scoring was used. PSGs were
ordered by the physician and AHI results were obtained from the medical record.
Results: Participants (N=170) were enrolled (88 male, 82 female; age 54.5, SD 5.0 years).
Almost all participants completed the self-report OSA screening measures, approximately half
completed PSM measurement, and the majority completed laboratory PSG. The STOP Bang had
the highest levels of sensitivity; the ESS had the lowest. The ESS had the highest specificity and
reliability level. The PSM measure had the highest positive predictive value (PPV). The PSM
measure had the strongest psychometric properties of the screening measures.
Conclusions: The STOP Bang was the preferred self-report OSA screening measure because of
high sensitivity levels. A positive STOP Bang warrants assessment for OSA. The ESS is the least
desirable screening measure. If a patient qualifies, further screening with a PSM is indicated.

PSM measurement consistently predicted the presence of OSA but at the expense of low
sensitivity at AHI levels ≥ 30. PSM results can guide the referral process from primary or
specialty clinicians to sleep specialists
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Chapter I: Background
Obstructive sleep apnea (OSA) is a common, yet underdiagnosed, sleep-related breathing
disorder that significantly contributes to all-cause (Kendzerska, Gershon, Hawker, Leung, &
Tomlinson, 2014; Qaseem et al., 2014) and cardiac mortality (Kendzerska et al., 2014). The
estimated prevalence rate of moderate to severe OSA in the United States is approximately 10%
to 20%. The rate is thought to be influenced by the obesity epidemic and to have increased
dramatically over the past two decades (Peppard et al., 2013).
Essential features of OSA include a repetitive partial (hypopnea) and/or complete (apnea)
obstruction of the upper airway, marked by upper pharyngeal collapse with continuing efforts to
breathe. Events can last 10 seconds to a minute in duration, resulting in intermittent desaturations
in oxyhemoglobin levels and sleep fragmentation. Respiratory-effort related arousals (RERAs)
are sequences of breaths with increased pressure for at least 10 seconds preceding an arousal with
more normal pressures. The results of apneas, hypopneas, and RERAs are intermittent hypoxia,
activation of oxygen free radicals, and an oxidative stress response (Berry et al., 2014). Longterm inflammatory processes result in changes in the vascular endothelium, leading to atheroma
formation and vascular events (Almendros et al., 2011; Xie, Pan, Ren, Du, & Guo, 2013).
A study by Torres et al. found that gender, age, body mass index, nocturnal heart rate,
and night and day-time blood pressure can be predictive of OSA. Other studies report a
relationship between OSA and tachyarrhythmias (Holmqvist et al., 2015; Kohli, Balachandran, &
Malhotra, 2011), reduced left ventricular stroke volume (Yumino et al., 2013), stroke (Lipford et
al., 2015), cognitive impairment (Aaronson et al., 2015), and insulin resistance (Heffner,
Rozenfeld, Kai, Stephens, & Brown, 2012).
Patients present to their health care providers with daytime sleepiness and/or known
OSA risk factors, such as obesity and CVD, but are not screened for symptoms, assessed, or
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referred to a sleep specialist for diagnosis and treatment for the disorder (Jennum, Ibsen, &
Kjellberg, 2013).
The American Academy of Sleep Medicine (AASM) released a call for volunteers to
serve on an OSA Assessment Tools Task Force. Two main goals for the task force are to evaluate
the current OSA screening measures and to recommend whether the AASM needs to develop
additional measures that improve detection of the disorder (American Academy of Sleep
Medicine, 2016).
The self-report screening measures used commonly to detect OSA are the Berlin
Questionnaire (Berlin) (Netzer, Stoohs, Netzer, Clark, & Strohl, 1999) and the Epworth
Sleepiness Scale (ESS) (Johns, 1991). The STOP Bang questionnaire has been used to predict
airways obstructive events in pre-operative patients in the acute care setting but more outpatient
validation studies are needed (Chung et al., 2008a). The increased need for polysomnography
(PSG) services encouraged the development of an objective screening measure, the portable sleep
monitors (PSM). Level III PSM, with four channels, are used for OSA screening and diagnosis in
patients who meet criteria. Reporting of the apnea hypopnea index (AHI) or respiratory distress
index (RDI) after PSM is mandatory for OSA diagnosis (Department of Health and Human
Services & Centers for Medicare & Medicaid Services, 2013). PSG remains the gold standard for
generating AHI levels ≥ 15 to diagnose OSA.
Theoretical Background
Kohli, Balachandran, and Malhotra (2011) developed a pathophysiologic model that
visually depicted the long-term effects of OSA on the cardiovascular system, titled “Effects of
Obstructive Sleep Apnea on the Cardiovascular System” (Figure 1). The construction of the
model was supported by epidemiological research. In the model, OSA is shown to have three
main effects: arousal, decreased partial pressure of oxygen (pO2) and increased partial pressure of
carbon dioxide (pCO2), and decreased intrathoracic pressure.
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Arousals are important to OSA because the diagnosis of the disorder is based upon the
number of apneas, hypopneas, RERAs, and/or respiratory distress index that are measured by
PSG. The frequent arousals result in sympathetic nervous system activation that cascades into
increased heart rate and blood pressure. The second main effect shown in the model is cyclic
hypoxemia (decreased pO2) and hypercapnia (increased CO2). These two effects result in
myocardial vasodilation and increased oxygen delivery as well as an increase in oxidative stress,
inflammation, and endothelial dysfunction. Lastly, a decrease in intrathoracic pressure causes an
increase in left ventricular wall tension and increased myocardial oxygen demand. The long-term
effects of OSA, shown at the bottom of the model, are hypertension, atherosclerosis, myocardial
ischemia, left ventricular hypertrophy and failure, cardiac arrhythmias, and cerebrovascular
disease.
Figure 1: Effects of Obstructive Sleep Apnea on the Cardiovascular System (Kohli et al.,
2011)
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Conceptual Framework
The conceptual framework for this study (Figure 2) was adapted from Kohli’s (Kohli et
al., 2011). The pathophysiological effects of OSA need to be prevented or reduced. Figure 2
illustrates the need for screening, assessment, and diagnosis of OSA. It is important to determine
which screening measurement(s) is/are the most reliable, valid and has the highest sensitivity and
specificity levels compared to PSG. The second component of this framework illustrates the
cardiovascular consequences of untreated OSA, which is not included in this study but will be in
future research. OSA diagnosis begins with the screening and assessment process. The screening
process is more efficient with the use of reliable and valid OSA screening measures. The OSA
screening measures selected were the Berlin, ESS, STOP Bang and a PSM (ApneaLink Air). The
screening measures were psychometrically compared with AHI levels from PSG.
Figure 2: Conceptual Framework Adapted from Kohli et al. (2011)
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The cardiovascular consequences included in the framework include tachycardia and
hypertension caused by systemic activation of the sympathetic nervous system. Because of the
excess stress placed on the body’s vascular system, blood pressure and heart rate increase along
with decreased myocardial oxygen delivery. The result is development of cardiovascular disease
(Kohli et al., 2011). Including the cardiovascular consequences of untreated OSA in the
framework provides emphasis of the benefits of early screening and treatment of the sleep
disorder.
The current practice pattern is inconsistent for screening and assessment of OSA. This
framework informs the study by emphasizing the importance of identifying measures that are
highly predictive of OSA. The knowledge gained from this study will determine which
measurement(s) has the best predictability for identifying OSA in undiagnosed patients in a sleep
clinic setting.
Definitions of Major Concepts
Obstructive sleep apnea
Essential features of OSA include a repetitive partial (hypopnea) and/or complete (apnea)
obstruction of the upper airway, marked by upper pharyngeal collapse with continuing efforts to
breathe (Berry et al., 2014). These events can last 10 seconds or up to a minute in duration, and
result in intermittent desaturations in oxyhemoglobin levels and sleep fragmentation. In obese
individuals, obstructive events in rapid eye movement sleep have been associated with lower
oxyhemoglobin desaturations (Peppard, Ward, & Morrell, 2009).
An AASM task force listed symptoms of OSA as loud snoring between apneas, witnessed
episodes of gasping for air, choking, and the presence of daytime sleepiness. The severity of OSA
is categorized by an individual’s AHI, indicating how many times an hour the patient experiences
obstructive events during PSG testing (Epstein et al., 2009). AHI levels range from mild (≥ 5 and
< 15), to moderate (15 ≥ and < 30 ), to severe (≥ 30 ) (Berry et al., 2014; Epstein et al., 2009;
Guilleminault, Benbir, & Aktar, 2007). Daytime excessive sleepiness, fatigue and feeling
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unrefreshed after sleep are common in most individuals with OSA and symptoms are exacerbated
by more frequent apnic and hypopenic events (Epstein et al., 2009), these can be detected using
sensitive and specific screening methods.
Screening
The definition for screening is “the act of doing a test on a person… to look for evidence
of a disease” (Merriam-Webster Dictionary, 2014b). OSA screening currently takes place via the
review of systems process but providers often do not include questions to detect sleep
disturbances (Grover et al., 2011; Senthilvel, Auckley, & Dasarathy, 2011). Screening needs to
occur during a routine health maintenance assessment or as part of a comprehensive exam for
high-risk patients (Epstein et al., 2009). Physiologic characteristics that place a person at highrisk of OSA are obesity (body mass index > 35), congestive heart failure, atrial fibrillation,
hypertension, type II diabetes, stroke, pulmonary hypertension, and nocturnal cardiac arrhythmias
(Epstein et al., 2009; Miller & Berger, 2016).
An OSA screening measure can be used to predict OSA and to determine whether an
assessment is warranted. The AASM Clinical Guidelines Task Force (Epstein et al., 2009)
reached “consensus” that several questions can be asked by the primary care provider (PCP)
during routine health maintenance assessments. Asking about a history of snoring and daytime
sleepiness lacks reliability and validity and has not resulted in increased referrals to sleep
specialists. PCPs need to use sensitive and specific measures to identify, high-risk patients for
referral to a sleep specialist.
Measurement
OSA screening measures have been developed to aid health care providers to screening
quickly for moderate to severe OSA in a variety of health care settings (Abrishami, Khajehdehi,
& Chung, 2010; Ramachandran & Josephs, 2009; Silva, Vana, Goodwin, Sherrill, & Quan,
2011). Using sensitive and specific screening measures offers a cost-effective way to predict the
presence of OSA and highlights the need to refer the patient to a sleep specialist. Measures with
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high positive predictive value are likely to predict the presence of a disease while those with high
negative predicative values are likely to predict the absence of the disease. This section will
discuss reliability and validity as well as provide a description of the OSA screening measures.
Reliability. Reliability testing helps determine whether the health outcomes under study
can provide reproducible results in the population. The reliability of a measurement is concerned
with controlling random error, which can be caused by inconsistent responses to questionnaires,
data entry errors, poor training of data collectors, or coding/transcription errors (Furr &
Bacharach, 2014).
Validity. DeVon et al. (2007) defined validity as “the ability of the instrument to measure
the attributes of the construct under study” (p.155). Validity can be divided into three categories of
measurement: (a) content, (b) criterion, and (c) construct validity (Kane & Radosevich, 2010).
Content, or face validity refers to the comprehensiveness of the measurement that is established via
content analysis. Criterion validity measures a correlation between an instrument and the gold
standard of measurement. This category of validity can be subdivided into concurrent and
predictive validity. Concurrent validity occurs when scores on a measure are correlated to related
criterion at the same point in time. Predictive validity is the degree to which test scores predict
performance on some future criterion, measured by sensitivity, specificity, positive predictive
value, and negative predictive value. Sensitivity is the probability of a positive test among patients
with a disease and specificity is the probability of a negative test among patients without a disease.
Positive predictive value is the probability that subjects with a positive screen will truly have the
disease and negative predictive value is the probability that subjects with a negative screen truly
don’t have the disease (Kane & Radosevich, 2010).
Construct validity uses scientific theory to support or refute a construct. Hypotheses can
test operational definitions to determine whether the overarching theory supports the instrument
being tested. Construct validity can be assessed by convergent/discriminant validity or known
groups testing. Convergent validity compares two scales purporting to measure the same construct
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that should be highly correlated/theoretically similar. Known groups testing uses a highly
sensitive/specific measure (i.e. PSG) to determine differences in groups (DeVon et al., 2007; Kane
& Radosevich, 2010).
Berlin questionnaire. The Berlin questionnaire (Netzer et al., 1999) was developed by
primary care and pulmonary physicians to predict the presence of OSA. The measurement has
three symptom categories; the first has five unique questions concerning frequency (rare to often)
of snoring and apneas while sleeping. The second category has four unique questions concerning
daytime sleepiness with a question about sleepiness while driving. A score is positive for
category 1 and 2 when a patient selects two responses from the top levels. The third category has
two questions. A positive response is when a patient has high blood pressure (> 140/90mmHg) or
a body mass index (BMI) > 30kg/m2. After scoring, the individual is considered to be high-risk if
two or three of the categories are positive.
Epworth sleepiness scale. The ESS (Johns, 1991) was developed as a simple measure to
quantify the level of daytime sleepiness in adults. The ESS is a brief scale that asks the subject to
rate on a scale of 0-3 (0=none, 3=high chance of dozing) the level of sleepiness during eight daily
activities. The sum of the eight questions is calculated and the higher the sum, the higher the
sleep deficit (0-24). A score of ≥16 indicates a high level of daytime sleepiness (Johns, 1991).
The ESS has been shown to be reliable in the test-retest sense. The measure has high internal
consistency (Johns, 1992) but inconsistent sensitivity and specificity values (El-Sayed, 2012;
Silva et al., 2011).
STOP Bang. The STOP Bang is an OSA screening measure that was developed to
quickly and concisely screen for OSA in a pre-surgical population. The eight OSA predictor
variables are snoring, tiredness, obstruction, high blood pressure, BMI, age, neck circumference,
and gender. Scoring takes place on a Yes/No scale (Chung et al., 2008a). The person is given one
point for each “yes” response. Scores range from 0 to 8, with ≥3 indicating a positive screen.
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ApneaLink Air. The ApneaLink AirTM (ResMed, San Diego, CA) is a level III, four
channel, PSM that is prescribed by a health care provider. The device monitors (a) oxygen
saturation, (b) heart rate, and (c) breathing patterns (apneas, hypopneas, snoring, probability of
Cheyne-Stokes breathing). No known figures of test-retest reliability have been reported. An AHI
level of ≥ 15 on the ApneaLink Air was the indicator of a positive screen (Collop et al., 2007).
Assessment
A more comprehensive sleep history is recommended when an OSA screen is positive or
the physician determines that assessment is warranted (Epstein et al., 2009). Assessment is
defined as “the act of making a judgment about something” (Merriam-Webster Dictionary,
2014a). No clinical measurement or assessment is absolutely predictive of the presence of OSA,
but patients assessed as high-risk for the disorder should be referred to a sleep specialist for
evaluation (Epstein et al., 2009).
Assessments included are BMI, neck circumference, blood pressure, and a visual
examination of the oro-naso-pharynx. Determining a Mallampati score is helpful in assessing
posterior pharyngeal crowding caused by increased upper airway soft tissue or abnormal facial
structures. Higher scores have been correlated with OSA severity (r= 0.351, p= 0.008) and may
predict nighttime obstructive events. A class 1 Mallampati score is visualization of the entire soft
palate; severity ranges to a class 4, which is the inability to see any part of the soft palate (Epstein
et al., 2009).
The assessment for OSA should include an examination of the cardiovascular and
respiratory systems (Epstein et al., 2009). Untreated OSA is more likely to be present in persons
with hypertension (Walia et al., 2014), or other cardiovascular conditions such as stroke (C. Chen
et al., 2015) and Type II diabetes (Wang, Bi, Zhang, & Pan, 2013). Untreated OSA in the
presence of dilated cardiomyopathy or ischemic heart disease can lead to the development of
congestive heart failure (D. J. Gottlieb et al., 2010). Patients with severe untreated OSA, who also
have chronic obstructive pulmonary disease, are at higher risk of developing pulmonary
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hypertension and cor pulmonale. When screening and assessment indicate that a patient found is
at high-risk for OSA, the referral process must be expedited for timely diagnosis and treatment
(Epstein et al., 2009).
Diagnosis
Polysomnography. Under supervision of a sleep technician, laboratory PSG is the gold
standard for OSA diagnosis. An AASM task force (2012) defined apnea events in adults as “a
drop in the peak signal excursion by ≥ 90% of pre-event baseline using an oro nasal thermal
sensor (diagnostic study), positive assisted pressure (PAP) device flow (titration study), or an
alternative apnea sensor, for ≥ 10 seconds”(p. 606). Hypopnea events in adults are scored when
“the peak signal excursions drop by ≥ 30% of pre-event baseline using nasal pressure (diagnostic
study), PAP device flow (titration study), or an alternative sensor for ≥ 10 seconds in association
with either ≥ 3% arterial oxygen desaturation or an arousal (Berry et al., 2012). The severity of
OSA has been defined by AASM as “an individual’s Apnea Hypopnea Index (AHI), which
indicates how many times an hour the patient experiences obstructive events” (Epstein et al.,
2009). AHI levels range from mild (≥ 5 and < 15), to moderate (15 ≥ and < 30), to severe (≥ 30)
(Berry et al., 2014; Epstein et al., 2009; Guilleminault et al., 2007).
Introduction of Documents
This dissertation adds to the current knowledge of OSA screening, assessment, and
diagnosis. The dissertation uses the three-manuscript option to present the current state of the
science on this topic. Chapter II is an integrative literature review titled State of the Science:
Screening and Assessment for Obstructive Sleep Apnea in Primary Care. Next, Chapter III is a
focused literature review titled Methodological Challenges: Using Portable Sleep Monitoring in
Research. Chapter IV.A. is the presentation of Aim 1 of the dissertation study as well as a
discussion of its theoretical and conceptual framework titled Psychometric Properties of
Obstructive Sleep Apnea Screening Measures in Patients Referred to a Sleep Clinic. Chapter
IV.B. is the presentation of Aim 2 of the dissertation study, which is a multiple regression
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analysis of demographic and clinical variables using AHI from laboratory PSG as the outcome
variable titled Analysis of Demographic, Clinical, and Biomarker Characteristics to Determine
Predictors of Apnea Hypopnea Index from Polysomnography in Midwestern Sleep Clinic
Patients. Chapter V presents conclusions and discussion of the research and implications for
research and practice.
Chapter II: State of the Science: Screening and Assessment for Obstructive Sleep Apnea in
Primary Care
OSA is the most common sleep-related breathing disorder and contributes to increased
morbidity and compromised cardiovascular outcomes. Sleep disorders are common but rarely
reported and addressed by primary health providers. An American Academy of Sleep Medicine
task force (2015) released quality measures for the care of adult patients with OSA; the first
outcome is improved detection and categorization of OSA symptoms and severity to promote
assessment and diagnosis of the disorder.
This state of the science integrative review aimed to evaluate the screening and
assessment for OSA in primary care settings including the psychometric properties of OSA
screening measures. This paper is the first to focus on this issue. Studies that met inclusion
criteria were fourteen non-experimental and three experimental designs. OSA screening measures
(Berlin Questionnaire, Epworth Sleepiness Scale, STOP Bang) with extensive validation studies
were examined. A critical evaluation of the current state of the science is provided as well as
recommendations for future interdisciplinary research.
Chapter III: Methodological Challenges in Using Portable Sleep Monitoring in Research
OSA in adults has been increasing over the last two decades. Currently, it is estimated
that moderate to severe OSA (apnea hypopnea index [AHI] ≥ 15) is present in 10% of men aged
30-49, 17% of men 50-70 years old, and 9% of women 50-70 years old. PSM type of testing is
not recommended for patients with co-morbid conditions such as moderate to severe pulmonary
disease, neuromuscular disease, congestive heart failure, or who are suspected to have other sleep
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disorders (central sleep apnea, periodic limb movement disorder, insomnia, parasomnias,
circadian rhythm disorders, or narcolepsy) (Collop et al., 2007). Because of the increase in OSA
prevalence, sleep laboratory and diagnostic services are in high demand; therefore, it was
necessary to identify alternative means for screening and diagnosis of sleep disorder outside of
the sleep laboratory.
The first practice parameters were released for PSM in 1994 (Ferber et al., 1994). By the
mid 1990’s, most devices measured snoring but did not meet diagnostic requirements for OSA.
By the year 2000, PSM were updated to include oxygen saturation, heart rate, oral/nasal airflow,
respiratory effort and body position (Cleveland Medical Devices Inc., 2016). In 2000, the Agency
for Healthcare Research and Research Quality (AHRQ) performed a meta-analysis that stated
broad use of PSM could not be supported due insufficient evidence (Ross et al., 2000). In 2007,
the Portable Monitoring Task Force of the AASM released guidelines which stated patients could
be screened and diagnosed with OSA in home settings with Level III PSMs (Collop et al., 2007).
This encouraged device manufacturers to develop PSM that allow patients to be screened or
diagnosed with OSA in home settings. PSM has increased in popularity in order to meet the
challenges of decreased availability of sleep laboratory sources.
With the increased use of PSM in outpatient settings, it is important to understand the
research that has been published on the topic using level III monitors and to be able to understand
the methodological challenges that are common with the use of the devices in research. To
provide a focused review on the methodological challenges when using portable sleep monitors in
research, it was necessary to create two main objectives for this manuscript. The first purpose of
this paper was to synthesize the literature of the methodological challenges in using level III PSM
in research adult patents, in terms of: (a) participant sampling; (b) instrumentation issues; (c)
clinical variables; (d) data processing options; and (e) patient acceptability. A second purpose was
to identify methodological strategies to use to standardize PSM information in research reports.
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After implementing the exclusion criteria, 33 publications were included in the focused review
and the strategies were identified from them.
Chapter IV.A. Psychometric Properties of Obstructive Sleep Apnea Screening Measures in
Patients Referred to a Sleep Clinic
There are no current guidelines for screening for OSA in outpatient settings due to
methodological issues with available measures. The screening measures that are often used to
detect OSA are the Epworth Sleepiness Scale (ESS) (Johns, 1991) and the Berlin Questionnaire
(Berlin) (Netzer et al., 1999). The STOP Bang questionnaire has been used to predict airways
obstructive events in pre-operative patients in the acute care setting but more outpatient validation
studies are needed (Chung et al., 2008a). A clinical practice guideline from the American College
of Physicians, released in 2014, discussed the use of screening questionnaires for individuals with
unexplained daytime sleepiness but states that they are not ready to be used as diagnostic tools for
OSA (Qaseem et al., 2014). As previously discussed, PSM allows patients to be screened or
diagnosed with OSA in home settings but limited studies discuss validation with screening
measures and laboratory PSG. The knowledge gained from this study contributes to science by
identifying the sensitivity and specificity of OSA measures used in screening.
Therefore, in patients who have been referred to a sleep specialist for a sleep disordered
breathing evaluation, the purpose of this methodological study was to identify the psychometric
properties of OSA screening measures (Berlin, Epworth Sleepiness Scale, STOP Bang,
ApneaLink Air) compared to AHI levels from PSG. Validation testing was completed with the
screening measures and conclusions were drawn in terms of implications for research and
practice.
Chapter IV.B. Analysis of Demographic, Clinical, and Biomarker Characteristics to
Determine Predictors of Apnea Hypopnea Index from Polysomnography in Midwestern
Sleep Clinic Patients

14
PSYCHOMETRIC PROPERTIES
OSA can occur in any age group but is most prevalent in older men (Kendzerska et al.,
2014) and post-menopausal women (Zhao et al., 2014). A recent population health study
concluded that the incidence of OSA is increasing because of rising obesity rates (Adams et al.,
2012). OSA has been associated with hypertension (D. J. Gottlieb et al., 2014), congestive heart
failure (D. J. Gottlieb et al., 2010), stroke (D. Gottlieb, Quan, Punjabi, Redline, & Bertisch,
2014), vascular disease (Cassar et al., 2014), metabolic disorders (N. H. Kim et al., 2013), and
coronary artery disease (Jennum et al., 2013; Young et al., 2008). Untreated OSA can exacerbate
all of these comorbid conditions (Colten & Altevogt, 2006).
Aim 2’s purpose was to examine if selected demographic (age, gender), clinical
(diabetes, coronary artery disease, hyperlipidemia, myocardial infarction, stroke, lung disease,
smoking history, alcohol intake), and biomarker (blood pressure, heart rate, BMI, neck
circumference, Mallampati Score) variables predict AHI levels from PSG. Significant predictor
variables from the model were discussed in the conclusion as well as implications for future
research and practice.
Chapter V: Discussion and Conclusions of the Dissertation Research
This chapter provides additional insights into the understanding of the conclusions of
these documents. Implications for research and practice are presented. Unique insights into
expanding validity testing of the STOP Bang and PSM are provided.
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Summary
Obstructive sleep apnea (OSA) is the most common sleep-related breathing disorder and
contributes to increased morbidity and compromised cardiovascular outcomes. Sleep disorders
are common but rarely reported and addressed by primary health providers. An American
Academy of Sleep Medicine task force (2015) released quality measures for the care of adult
patients with OSA; the first outcome is improved detection and categorization of OSA symptoms
and severity to promote assessment and diagnosis of the disorder.
This state of the science integrative review aimed to evaluate the screening and
assessment for OSA in primary care settings including the psychometric properties of OSA
screening measures. Studies that met inclusion criteria were fourteen non-experimental and three
experimental designs. OSA screening measurements (Berlin questionnaire, Epworth sleepiness
scale, STOP Bang) with extensive validation studies were examined. Conclusions are that the
current practice model of screening and assessment for OSA in primary care is fragmented and
ineffective. Primary care providers encounter patients with OSA symptoms but do not routinely
screen, assess, or refer to a sleep specialist. More psychometric research is needed for the OSA
screening measurements in primary care. The results of these studies can be translated into
practice to increase detection of OSA.

Keywords: assessment; cardiovascular; evaluation; obstructive sleep apnea; measurement;
screening; sleep related breathing disorders
Abbreviations: AHI, apnea hypopnea index; BMI, body mass index; EMR, Electronic medical
record; ESS, Epworth sleepiness scale; PAP, positive airway pressure; PCP, primary care
provider; PSG, polysomnography; OSA, obstructive sleep apnea; US, United States
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Chapter II: Screening and Assessment for Obstructive Sleep Apnea in Primary Care
Introduction
Obstructive sleep apnea (OSA) is the most common sleep-related breathing disorder
(National Heart, Lung, and Blood Institute, 2012) and contributes to increased morbidity and
compromised cardiovascular outcomes (Campos-Rodriguez et al., 2012; Kendzerska et al., 2014;
Qaseem et al., 2014). The pathologic cardiovascular changes associated with OSA result from
multifactorial etiologies. Repetitive obstructive events during sleep are hypothesized to cause
intermittent hypoxia, resulting in activation of oxygen free radicals and an oxidative stress
response. A concurrent inflammatory process suggests that damage to the vascular endothelium
leads to atheroma formation and vascular events (Almendros et al., 2011; Xie et al., 2013).
Epidemiological studies have concluded that untreated severe OSA is a large public health burden
in terms of cardiac morbidity and mortality (D. J. Gottlieb et al., 2013; Kendzerska et al., 2014).
In 2015, an American Academy of Sleep Medicine (AASM) task force released quality measures
for the care of adult patients with OSA. The first quality measure outcome is to improve detection
and categorization of OSA symptoms and severity (Aurora et al., 2015).
Bailes and colleagues (2008; 2009) surveyed primary care and sleep clinic patients and
found that sleep disorders are common but rarely addressed by primary care providers (PCP). A
Canadian population-based study found that patients often do not report sleep disturbance
consequences to their PCP because their symptoms are chronic and difficult to explain (Bartlett,
Marshall, Williams, & Grunstein, 2008). Daytime functioning complaints or insomnia symptoms
are not recognized as consequences of OSA (Bailes et al., 2009). Congruently, many PCPs do not
routinely screen or assess for sleep disturbances (Burgess, Havryk, Newton, Tsai, & Whitelaw,
2013; Grover et al., 2011). Patients present with known OSA risk factors, such as obesity and
CVD, but are not screened for symptoms, assessed, or referred to a sleep specialist for diagnosis
and treatment for the disorder (Jennum et al., 2013). Because PCPs and other clinicians fall short
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in recognizing OSA, more education is needed to detect patients at high-risk for the sleep
disorder.
Background
OSA can occur in any age group, but is most prevalent in older men (Kendzerska et al.,
2014) and post-menopausal women (Zhao et al., 2014). OSA may be poorly recognized in premenopausal women because symptoms are often nonspecific, such as insomnia, headaches, or
fatigue (Attarian & Viola-Saltzman, 2006). A recent population health study concluded that the
incidence of OSA is increasing in men and women due to rising obesity rates and practitioners
need to adopt a proactive approach to diagnosis (Adams et al., 2012). Cardiovascular disease is
the leading cause of mortality in the United States (US) (J. I. Kim, Sillah, Boucher, Sidebottom,
& Knickelbine, 2013). Both the National Institutes of Health (2013) and the American Heart
Association (2013) have emphasized the need to improve cardiovascular health nationwide. OSA
is associated with cardiovascular disease (Cassar et al., 2014; D. J. Gottlieb et al., 2014; D. J.
Gottlieb et al., 2010; N. H. Kim et al., 2013; Young et al., 2008) and can exacerbate comorbid
conditions (Colten & Altevogt, 2006), placing a significant burden on US health care system.
The US Preventative Task Force, the American Academy of Family Physicians, and the
Center for Disease Control have not made recommendations for OSA screening or assessment
(Senthilvel et al., 2011). No OSA practice guidelines have been released from any major internal
or family practice organizations regarding screening and assessment. This demonstrates that sleep
is undervalued in healthcare. The 2014 American College of Physicians summary includes use of
screening questionnaires for individuals with unexplained daytime sleepiness (Qaseem et al.,
2014). However, daytime sleepiness is often not reported by patients with OSA and screening for
other symptoms is warranted (Bailes et al., 2009).
New Healthy People 2020 guidelines (2015) were released by the Office of Disease
Prevention and Health Promotion and “Sleep Health” was listed as a national priority. Three
objectives that are pertinent to improving health outcomes in persons with OSA are: (SH-1)
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increasing the proportion of persons with symptoms of OSA who seek medical attention; (SH-2)
reduce the rate of vehicular crashes per 100 million miles traveled that are due to drowsy driving;
and (SH-4) increasing the proportion of adults who get sufficient sleep (Office of Disease
Prevention and Health Promotion, 2015). With PCPs managing chronic conditions and acute
events, there is often inadequate time for screenings that are not recommended (Sorscher, 2008).
Awareness of the long-term impact of undiagnosed OSA on the cardiovascular system needs to
stimulate increased OSA screenings in primary care.
Multiple treatment options for OSA have been shown to improve quality of life in
patients with high adherence levels; however, positive airway pressure (PAP) therapy is
considered the first line treatment for moderate to severe OSA (American Sleep Apnea
Association, 2015). The AASM recommends using PAP therapy to reduce levels of daytime
sleepiness and improve patients’ quality of life (Aurora et al., 2015). Understanding the benefit of
OSA treatments highlights the importance of screening for the sleep disorder.
This state of the science integrative review aimed to evaluate the screening and
assessment for OSA in primary care settings including the psychometric properties of OSA
screening measures. This paper is the first to focus on this issue. A critical evaluation of the
current state of the science is provided as well as recommendations for future interdisciplinary
research.
Methods
An electronic literature search was conducted by the authors and a medical librarian
using the databases of Cumulative index to nursing and allied health literature (CINAL),
Cochrane, Excerpt medical database (EMBASE), and PubMed. Other relevant publications were
found via obtained articles. The time frame from January 1991- June 2014 was used to include
the original article of the Epworth sleepiness scale. Keywords in the literature search included but
were not limited to: “Obstructive sleep apnea”, “adults”, “sleep-related breathing disorders”,
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“screening”, “assessment”, “primary care”, “primary care providers”, “health care providers”,
“internal medicine”, and “OSA screening tools”.
Specific journal articles were included in the literature review based on the following
criteria: 1. published in the English language, 2. participants studied in primary care
setting/internal medicine, 3. providers practicing in primary care/internal medicine, 4. included an
OSA screening process, 5. compared OSA screening tools, and 6. used OSA assessment criteria.
Studies were excluded if: 1. conducted in any setting other than primary care/internal medicine, 2.
focused on sleep disorders other than OSA, 3. discussed long-term management of OSA in
primary care settings, 4. focused on management of OSA patients by sleep physicians, and 5.
used children as participants. Adult OSA screening in primary care and internal medicine settings
is the focus of this article because early detection of the sleep disorder can improve health and
reduce risk of cardiovascular diseases. PCPs often see patients on a regular basis, allowing time
to screen and assess for risk of chronic health conditions.
Search Results
In the initial search, 2,869 records were found. After deleting 553 duplicates, 2,316
records remained. Relevant articles were reviewed by the first author and the medical librarian
and verified by the second author from the following databases: 63 in CINAL, 0 in Cochrane, 804
in EMBASE and 1,450 in PubMed. After implementing the exclusion criteria, 17 articles met
criteria for this integrative literature review (Figure 1).
Definitions
Obstructive sleep apnea
Essential features of OSA include a repetitive partial (hypopnea) and/or complete (apnea)
obstruction of the upper airway, marked by upper pharyngeal collapse with continuing efforts to
breathe (Berry et al., 2014). These events can last 10 seconds or up to a minute in duration, and
result in intermittent desaturations in oxyhemoglobin levels and sleep fragmentation. In obese
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individuals, obstructive events in REM sleep have been associated with lower oxyhemoglobin
desaturations (Peppard et al., 2009).
An AASM task force listed symptoms of OSA as loud snoring between apneas, witnessed
episodes of gasping for air, choking, and the presence of daytime sleepiness. The severity of OSA
is categorized as an individual’s Apnea Hypopnea Index (AHI), which indicates how many times
an hour the patient experiences obstructive events during polysomnography (PSG) testing
(Epstein et al., 2009). AHI levels range from mild (≥ 5 and < 15), to moderate (15 ≥ and < 30 ), to
severe (≥ 30 ) (Berry et al., 2014; Epstein et al., 2009; Guilleminault et al., 2007). Daytime
excessive sleepiness, fatigue and feeling unrefreshed after sleep are common in most individuals
with OSA and symptoms are exacerbated by more frequent apnic and hypopnic events (Epstein et
al., 2009), these can be detected using sensitive and specific screening methods.
Screening
Screening for OSA needs to take place in any adult who reports OSA symptoms (Table
1) (Epstein et al., 2009). The definition for screening is “the act of doing a test on a person… to
look for evidence of a disease” (Merriam-Webster Dictionary, 2014b). In primary care settings,
the patient will most likely be screened by a mid-level provider (nurse practitioner and/or
physician’s assistant) or physician to determine if he/she is experiencing OSA symptoms. OSA
screening currently takes place via the review of systems process but providers often do not
include questions to detect sleep disturbances (Grover et al., 2011; Senthilvel et al., 2011).
Screening needs to occur during a routine health maintenance assessment or as part of a
comprehensive exam for high-risk patients (Epstein et al., 2009). Physiologic characteristics that
place a person at high-risk of OSA are listed in Table 2.
PCPs need to focus on signs and symptoms of sleep disturbances while conducting their
review of systems (Epstein et al., 2009). If the patient reports these symptoms, occupation should
be addressed. The Federal Motor Carrier Safety Administration has not released regulations for
OSA screening (Hartenbaum, 2010), but a recent expert review board recommended further
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evaluation of any commercial driver with a body mass index (BMI) of 33 or higher (Federal
Motor Carrier Safety Administration, 2008). An OSA screening measure can be used to predict
OSA and to determine whether an assessment is warranted. A progressive model of care in
Australia involved early referral by PCPs of symptomatic high-risk patients to sleep specialists
(Mansfield, Antic, & McEvoy, 2013). Increased detection of OSA will lead to higher demand for
sleep specialist services in the US. Mid-level providers can be trained to specialize in sleep
disorders accommodate for the influx of patients.
The AASM Clinical Guidelines Task Force (2009) reached “consensus” that several
questions can be asked by the PCP during routine health maintenance assessments. Asking about
a history of snoring and daytime sleepiness lacks reliability and validity and has not resulted in
increased referrals to sleep specialists. PCPs need to use a sensitive and specific measurement to
identify symptomatic, high-risk patients for referral to a sleep specialist.
Measurement
OSA screening measures have been developed to aid health care providers in quickly
screening patients for moderate to severe OSA in a variety of health care settings (Abrishami et al.,
2010; Ramachandran & Josephs, 2009; Silva et al., 2011). Using sensitive and specific screening
measures offers a cost-effective way to predict the presence of OSA and highlights the need to refer
the patient to a sleep specialist. Measures with high positive predictive value are likely to predict
the presence of a disease while those with high negative predicative values are likely to predict the
absence of the disease. Screening measurements with extensive validation studies are discussed in
this review. See Table 3 for detailed psychometric information on the most widely tested OSA
screening measurements.
Berlin questionnaire. The Berlin questionnaire (1999) was developed by primary care
and pulmonary physicians to predict the presence of OSA. The measurement has three symptom
categories; the first has five unique questions concerning frequency (rare to often) of snoring and
apneas while sleeping. The second category has four unique questions concerning daytime
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sleepiness with a question about sleepiness while driving. A score is positive for category 1 and 2
when a patient selects two responses from the top levels. The third category has two questions. A
positive response is when a patient has high blood pressure (> 140/90mmHg) or a BMI >
30kg/m2. After scoring, the individual is considered to be high-risk if two or three of the
categories are positive. The measurement was compared to home PSG testing; internal reliability
testing showed category 1 (snoring) was acceptable but Category 2 (daytime sleepiness) was low
(Netzer et al., 1999). Chung et al. (2008b) and El-Sayed (2012) found this questionnaire to have
higher levels of sensitivity when compared to specificity. Netzer et al. (1999) reported
inconsistent sensitivity and specificity levels. Low sensitivity and inconsistent levels of positive
and negative predicative values are limitations (El-Sayed, 2012; Netzer et al., 1999). This OSA
screening measure has documented psychometric properties in primary care settings (Chung,
2011).
Epworth sleepiness scale. The ESS (1991) was developed as a simple measure to
quantify the level of daytime sleepiness in adults. The ESS is a brief scale that asks the subject to
rate on a scale of 0-3 (0=none, 3=high chance of dozing) the level of sleepiness during eight daily
activities. The sum of the eight questions is calculated and the higher the sum, the higher the
sleep deficit (0-24). A score of ≥16 indicates a high level of daytime sleepiness (Johns, 1991).
The ESS has been shown to be reasonably reliable in the test-retest sense, have high internal
consistency (Johns, 1992), and inconsistent sensitivity and specificity values (El-Sayed, 2012;
Silva et al., 2011). El-Sayed (2012) reported that the ESS has high positive predictive values but
lower negative predictive values. The ESS has been used by PCPs to identify patients with
daytime sleepiness (Silva et al., 2011). This may be problematic if used alone because OSA
severity does not always correlate with symptomatic sleepiness (Ramachandran & Josephs,
2009).
STOP and STOP Bang Measurements. The STOP is an OSA screening measure that
was developed to quickly and concisely screen for OSA in a pre-surgical population. The four
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OSA predictor variables are snoring, tiredness, obstruction and high blood pressure on a Yes/No
scale (Chung et al., 2008a). A pilot study found that the STOP questionnaire was effective in
identifying patients with OSA, but the addition of four variables (BMI > 35kg/m, age >50 years
old, neck circumference > 40 cm, and male gender) increased the sensitivity of the measurement
(Chung et al., 2008a; El-Sayed, 2012; Silva et al., 2011).
The new variables were added to the measurement, creating the eight “yes/no” question
acronym STOP Bang (Chung et al., 2008a; Chung et al., 2012). The person is given one point for
each “yes” response. Scores range from 0 to 8, with ≥3 indicating a positive screen. El-Sayed
(2012) reported that the sensitivity of the STOP Bang stayed consistent from the previous STOP
version. Higher scores have been shown to correlate with the individual’s OSA severity (AHI>5,
sensitivity 0.836, AHI>15, sensitivity 0.923, AHI>30, sensitivity 1.0) (Chung et al., 2008b). Data
are limited on the reliability of the STOP Bang in primary care settings.
With the differences in patient populations, demographics, and ethnicities, scientists must
be mindful of the limitations of the psychometric data.
Assessment
A more comprehensive sleep history is recommended when an OSA screen is positive or
the physician determines that further assessment is warranted (Epstein et al., 2009). Assessment is
defined as “the act of making a judgment about something” (Merriam-Webster Dictionary,
2014a). No clinical measurement or assessment is absolutely predictive of the presence of OSA,
but patients deemed high-risk for the disorder should trigger a referral to a sleep specialist for
further evaluation (Epstein et al., 2009).
Assessments recommended are BMI, neck circumference, blood pressure, and a visual
examination of the oro-naso-pharynx. Determining a Mallampati score is helpful in assessing
posterior pharyngeal crowding caused by increased upper airway soft tissue or abnormal facial
structures. Higher scores have been correlated with OSA severity (r= 0.351, p= 0.008) and may
predict nighttime obstructive events. A class 1 Mallampati score is visualization of the entire soft
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palate; severity ranges to a class 4, which is the inability to see any part of the soft palate. A
referral to a sleep specialist is indicated when the health care provider determines the patient is atrisk for OSA (Epstein et al., 2009).
The assessment for OSA should include an examination of the cardiovascular and
respiratory systems (Epstein et al., 2009). Untreated OSA can occur in persons with hypertension
(Walia et al., 2014), along with other conditions such as stroke (C. Chen et al., 2015) and Type II
diabetes (Wang et al., 2013). Untreated OSA in presence of dilated cardiomyopathy or ischemic
heart disease can lead to the development of congestive heart failure (D. J. Gottlieb et al., 2010).
Patients with severe untreated OSA, who also have chronic obstructive pulmonary disease, are at
higher risk of developing pulmonary hypertension and cor pulmonale. When screening and
assessment indicate that a patient found is at high-risk for OSA, their referral process must be
expedited for timely diagnosis and treatment (Epstein et al., 2009).
Findings
This state of the science integrative review aimed to evaluate the screening and
assessment for OSA in primary care settings including the psychometric properties of OSA
screening measures. The literature published in this area consists of 14 non-experimental and 3
experimental designs (Table 4). All studies were conducted in the US unless otherwise stated.
Non-Experimental Designs
Cross-sectional descriptive studies. Seven studies aimed to screen undiagnosed, highrisk populations for presence of OSA symptoms. Five studies focused on the importance of early
screening in high-risk patient populations in several countries (Alam, Chengappa, & Ghinassi,
2012; BaHammam, Alrajeh, Al-Jahdali, & BinSaeed, 2008; BaHammam, Al-Rajeh, Al-Ibrahim,
Arafah, & Sharif, 2009; Burgess et al., 2013; Haponik et al., 1996; Netzer et al., 2003). One
Israeli primary care office developed a symptom checklist to assess PCPs awareness of OSA
during patient interactions (Reuveni et al., 2004). Burgess et al.(Burgess et al., 2013), used a two
channel OSA screening device in Australia.
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BaHammam and colleagues (2009), reported a 39% prevalence of severe OSA
symptoms in middle aged Saudi women and 33.3% in middle aged Saudi men (BaHammam et
al., 2008) using the Berlin questionnaire. Netzer et al. (2003) performed a standardized survey of
primary care patients to assess OSA risk factors and symptom frequency in a variety of countries
(US, Germany, Spain). The survey results indicated that adults in the US had a higher likelihood
of being at high-risk compared to adults in the European countries. Alam and colleagues (2012)
screened primary care patients with severe mental illness for OSA using the STOP Bang and
ESS. A high percentage of the patients with severe mental illness screened positive for OSA
using the STOP Bang when compared to the ESS. The majority of patients screened as high-risk
for OSA had never discussed the disorder with their PCP (Alam et al., 2012).
Burgess et al. (2013) used an unattended 2- channel OSA screening device, called
ApneaLink+O2, in high-risk patients. A high diagnostic accuracy was found in the OSA moderate
to severe range compared to PSG. Haponik et al. (1996) used medical interns to pose as primary
care patients. The histories taken by PCPs were analyzed to determine if unsolicited questions
were asked regarding snoring, non-restorative sleep, day time sleepiness, or witnessed apneas.
PCPs did not ask about signs of OSA or educate the patients on risk factors for the disorder
(Haponik et al., 1996).
Reuveni et al. (2004) assessed the awareness level of OSA symptoms in PCP in Israel by
providing standardized patient scenarios to indicate the need for further sleep disordered
breathing assessment. PCPs understood the algorithms for diagnosis of the disorder but could not
identify patients in need of diagnosis and treatment. The authors recommended development of
educational programs to increase PCP’s knowledge of OSA (Reuveni et al., 2004).
Overall, the studies were consistent in reporting OSA symptoms and risk factors in
primary care patients. PCPs often encounter patients who are in need of further assessment,
diagnosis, and treatment but for various reasons, are referred to a sleep specialist.
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Retrospective studies. Four studies were found that retrospectively examined OSA
screening and assessment in primary care patients. A Canadian study used prospective and
retrospective methods and encouraged participants to complete a sleep symptom checklist to
discuss with their health care provider during a sleep screening process. Researchers followed-up
after one year and found that 13.6% accepted further sleep evaluation and completed overnight
PSG (Bailes et al., 2009). One retrospective chart review evaluated what sleep history questions
were asked during the screening process. Kramer et al. (1999) found that only a small group of
physicians ordered sleep studies and the patients that were referred tended to be obese and to have
overt OSA symptoms. Sorscher (Sorscher, 2008) used a health database to determine if family
medicine physicians asked sleep disorder questions such as hypersomnolence and sleep
disordered breathing, insomnia, and parasomnias. Family medicine clinics didn’t screen for sleep
disorders as often as lifestyle/behavioral issues.
An Australian population-based survey described the prevalence of persons visiting their
primary care physicians for insomnia and/or OSA symptoms. , A population-weighted prevalence
for reporting a doctor visit for snoring/sleep apnea symptoms was 6.2% (Bartlett et al., 2008).
In summary, most of the studies found that PCPs rarely screen for OSA symptoms
without prompting from the patient (Bailes et al., 2009; Bartlett et al., 2008; Sorscher, 2008).
When screening did occur, very few patients were referred to a sleep specialist and many
mentioned symptoms without follow-up from health care providers (Kramer et al., 1999).
Correlational descriptive studies. Two correlational descriptive design studies used at
least one OSA screening measurement (Berlin questionnaire, Cleveland sleep habits
questionnaire, ESS or STOP) to help identify patients who were at high-risk (Demede et al.,
2011; Senthilvel et al., 2011). Senthilvel et al. (2011) found that only one of the 111 subjects was
suspected of having OSA by the blinded physicians. The PCP’s did not routinely screen for OSA,
which may have been influenced by lack of time and reimbursement. The authors suggested PCP
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use valid and reliable measurements to screen for OSA to better identify high-risk patients
(Senthilvel et al., 2011).
Demede et al. (2011) studied the prevalence of resistant hypertension in AfricanAmerican patients and determined if they were at high-risk for OSA using the ESS via an Apnea
risk evaluation system. Patients with resistant hypertension were at 2.5 times higher risk for OSA
than those with treatable hypertension; conclusions were that comorbid conditions are a public
health concern in African-Americans. Diagnosing and treating patients with OSA reduces
cardiovascular risk and improves outcomes for persons with resistant hypertension (Demede et
al., 2011; Dernaika, Kinasewitz, & Tawk, 2009).
Mixed method study. Mold et al. (2011) used a mixed method design to determine the
proportion of primary care patients at high-risk for OSA, the methods used by primary care
clinicians to identify them, and the proportion of those at high-risk who were diagnosed and
treated. Primary care offices were randomly selected in five US states to conduct physician and
patient interviews/assessments using the Berlin questionnaire and chart audits. Sleep consultants
were also interviewed to discuss referrals for OSA diagnostics. Findings were that OSA patients
were more accurately detected with the Berlin Questionnaire. Less than 25% of the PCPs
screened patients routinely for OSA using a review of systems method. According to the PCP
qualitative interviews, 84% of patients referred to a sleep specialist were positive for OSA.
Findings from this study indicate that 70-99% of primary care patients who were referred to a
sleep specialist had untreated severe OSA. This study exemplifies scientific rigor in sleep
research.
Overall, these studies reported that PCPs often did not detect OSA symptoms. Screening
measures used in the studies assisted the PCPs in identifying at-risk patients (Demede et al.,
2011; Senthilvel et al., 2011).
Experimental Designs.
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The authors identified three experimental design studies that used different
methodologies. Both Grover et al. (2011) and Namen et al (1999) used a prospective, two-group
design. Grover et al (2011) studied adults undergoing preventative exams at family medicine
clinics and determined whether a review of systems form identified sleep complaints.
Approximately one-third of participants reported sleep problems on the review of systems form
and less than one-fourth of complaints were documented by the PCPs. The review of systems
form identified persons with OSA when used as a screening measure but few sleep complaints
were investigated by PCPs. Namen et al. (1999), studied the frequency of sleep history
documentation and assessed whether randomized chart reminders prompted physicians to conduct
sleep histories. Each of the physicians were randomly assigned one chart with a sleep history
prompt and one without. The chart reminders increased the number of documented sleep histories
but sleep disturbance reports did not impact diagnosis or treatment of the patients’ disorders.
Ball et al. (1997) aimed to increase recognition of sleep disorders by PCPs in rural
western US via patient questionnaires, PSG, and chart reviews. The researchers held a training
session for PCPs taught by sleep specialists, who then taught PCPs how to interpret sleep testing
data. Prior to the intervention, few charts had documentation of a sleep-related condition. Post
intervention, the majority of PCPs ordered PSGs for their patients. Using sleep specialists to train
rural PCPs in sleep medicine is an example of a cost -effective way to use interdisciplinary
teamwork to increase access to OSA diagnostic testing.
Overall, these studies demonstrated that interventions that used a review of systems form
or chart reminders can increase documentation of sleep complaints. Likewise, specialized sleep
training for PCPs may increase referrals for sleep consultations and PSGs.
Discussion
This integrative review will now discuss the strengths, limitations, and implications
related to the state of the science of screening and assessment for OSA in primary care settings
including the psychometric properties of OSA screening measures. The strengths of the literature
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are the overall consensus that there needs to be routine screening and assessment for OSA in
primary care settings. The results support findings that OSA is associated with exacerbation of
comorbid conditions and risk for increased mortality and morbidity (Alam et al., 2012;
BaHammam et al., 2008; BaHammam et al., 2009; Ball et al., 1997; Burgess et al., 2013;
Haponik et al., 1996; Mold et al., 2011; Netzer et al., 2003). The authors conclude that there is a
lack of recognition of OSA symptoms by PCPs, whether or not the patient complains of daytime
sleepiness (Bailes et al., 2009; Bartlett et al., 2008; Namen et al., 1999; Sorscher, 2008). Even
more concerning is the agreement that PCPs are aware of the need to improve cardiovascular
health, but aren’t proactive in screening and assessment for OSA (Demede et al., 2011; Grover et
al., 2011; Kramer et al., 1999; Reuveni et al., 2004; Senthilvel et al., 2011). This may be because
screening measures need to demonstrate higher sensitivity, specificity, and predictive values
before PCPs will adopt them. Findings report inconsistent psychometric findings for OSA
screening measures with a lack of validation research in primary care (Abrishami et al., 2010; ElSayed, 2012; Ramachandran & Josephs, 2009; Silva et al., 2011). PCP must recognize the
importance of referrals to sleep specialists to earlier diagnose and treat OSA and improve patient
outcomes. Overall, this review showed that the current practice model of screening and
assessment for OSA in primary care is fragmented and ineffective.
This state of the science on screening and assessment of OSA patients in primary care
settings is not without limitations. Not all OSA screening measurements that have been reported
to be reliable and valid in primary care settings were included. Some studies may have been
missed during the literature search process. No studies reported information on patients’
willingness to be referred to sleep specialists. Lastly, several included studies did not explicitly
state the research design and only one used participant randomization.
Implications for Research
Currently, there is no guideline for OSA screening in primary care. Studies are needed to
further test a review of systems form or chart reminders. Inadequate screening is due in part to
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inconsistent psychometric results from current OSA screening measures. More validation testing
of the OSA screening measures is needed in primary care before a conclusion can be made
regarding which tool has the best OSA predictability. Before a guideline can be developed, the
OSA measurements used in primary care need to have high levels of sensitivity, specificity, and
positive predictive values to reliably screen patients for OSA. The testing of OSA screening
instruments must be conducted in large-scale, nationwide, studies that assess implementation in
primary care settings. Considerations for a reference standard might include identification of
adults with signs and symptoms, or conditions, associated with high risk for OSA. The
development of an OSA screening guideline might reduce cardiovascular mortality in at-risk
patients as long as the patient is adherent to the prescribed treatment. This is an area where
research can have a large impact on cardiovascular health nationwide.
The AASM (2015) has recommended the integration of screening for sleep disorders in
the Electronic medical record (EMR) as a health care priority. A task force is currently
developing a series of sleep-related data fields. Future screening and assessment protocols may be
integrated into the EMR to standardize the process. Translational research needs to provide
evidence for using the EMR as a database for OSA screening and referrals from PCPs to sleep
specialists.
Conclusion
Screening and assessment for OSA needs to be a priority in primary care settings. PCPs
need to use measurements that accurately predict the presence of OSA. The STOP Bang and
Berlin questionnaires serve as the current best measures to predict the presence of moderate to
severe OSA (Ramachandran & Josephs, 2009; Silva et al., 2011). The ESS is a measure of
daytime sleepiness (Johns, 1991) that can be used to help determine the level of daytime
impairment. The STOP Bang and the Berlin questionnaires have the highest sensitivity of the
measurements studied but at the expense of specificity (El-Sayed, 2012). The measurements do
not perform well at excluding low risk for OSA. It is unclear at this time due to inconsistencies of
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the psychometric properties which screening measure best predicts OSA in the primary care
setting. More research is needed to determine psychometric properties of OSA screening
measurements in primary care. The results from these studies can be translated into practice to
better detect OSA in primary care patients.
PCPs need to be educated on how to detect OSA and its long-term effects on
cardiovascular morbidity and mortality. Increased use of reliable and sensitive OSA screening
tools in primary care will lead to earlier and more frequent detection of the sleep disorder and to a
higher demand of sleep specialists’ services. More mid-level providers (nurse practitioners and
physician assistants) will need to be trained in sleep medicine to care for the influx of patients.
It is important to diagnose and treat OSA and cardiovascular disease as co- morbid
conditions. By screening and assessing patients who are at risk for OSA in primary care settings,
cardiovascular outcomes may stabilize and/or improve. Few studies have reported the screening
and assessment process of OSA in primary care settings. The current state of the science will
benefit from research on the psychometric properties of OSA screening measures in primary care
settings.
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Practice Points
1.

Adults often present with signs and symptoms or conditions associated with
high risk for OSA but are not screened, assessed, or referred to a sleep
specialist for diagnosis and treatment.

2.

When an OSA screen is positive recommendations are to assess BMI, neck
circumference, blood pressure and Mallampati score.

3.

Reliable and valid measurements offer a cost effective way to screen for
OSA and, when indicated, to expedite referral to a sleep specialist.

Research Agenda
1.

Conduct more validation testing of the OSA screening measures in primary
care before a conclusion is made of which tool has strongest predictability

2.

Develop an evidence-based OSA screening guideline to promote earlier
detection of the disorder.

3.

Determine whether embedding OSA screening and assessment guideline in
the EMR results in increased number of patients screened, assessed,
diagnosed, and treated.
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Figure 1: Literature Search Results
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Table 1
OSA Signs and Symptoms
a.

Snoring

b.

Witnessed apneas

c.

Nocturnal gasping/choking

d.

Unexplained daytime sleepiness

e.

Large neck size (≥ 17 inches for men, ≥ 16 inches for women)

f.

Sleep fragmentation/insomnia

g.

Non refreshing sleep

Adapted from Epstein et al. (2009)
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Table 2
Conditions Associated with High Risk of Obstructive Sleep Apnea
a.

Obesity (BMI>35)

b.

Cardiac or metabolic comorbid conditions (congestive
heart failure, atrial fibrillation, hypertension, Type 2
Diabetes, nocturnal cardiac dysrhythmias, stroke,
pulmonary hypertension)

c.

Pre-operative bariatric surgery

Adapted from Epstein et al. (2009)
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Table 3
Psychometric Properties of OSA Screening Measurements
OSA instruments
Population
Number of
(year),

/Country

items

Reliability

Sensitivity/Specificity

PPV/NPV

(95% CI)

(95% CI)

(95% Cl)

(AHI ≥ 15)

(AHI ≥ 15)

Country
Berlin questionnaire

Primary care,

Category 1

Category 1 α = 0.92

(1992), Germany41

Germany41

( 5 questions)

Category 2 α = 0.6341

Perioperative,

0.54/0.9741

PPV=0.9741

Category 2

0.79

0.51

Canada42

(4 questions)

(0.67, 0.88)/

(0.42, 0.61)/

Sleep clinic,

Category 3

0.51

0.78

Egypt43

(1 question)41

(0.41, 0.62)42

(0.67, 0.87)42

0.95

0.87

(0.91, 0.98)/

(0.82, 0.91)/

0.07

0.20

(0.01-0.24)43

(0.03-0.56)43

845

α= 0.8846

0.39, 0.7140

Epworth

Persons with

sleepiness scale

sleep disorders

(ESS) (1991),

and controls,

0.76

0.91

Australia45

Australia45

(0.69-0.82)/

(0.85, 0.95)/

Medical

0.48

0.23

students,

(0.29, 0.68)43

(0.13, 0.36)43

Australia46
Persons with
cardiovascular
disease,
United States40
Sleep clinic,
Egypt43
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STOP (2008),

Perioperative,

Canada47

Canada47,48

447

Test-retest, k= 0.93

0.74

0.51

(0.82-1.00)47

(0.62, 0.84)/

(0.41, 0.60)/

Persons with

0.53

0.76

cardiovascular

(0.43, 0.63)47,48

(0.64,0.85)47,48

disease,
United States40

0.62/0.5640

Sleep clinic,
Egypt43

848

None reported

0.95

0.89

(0.89, 0.97)/

(0.84, 0.93)/

0.26

0.41

(0.11, 0.46)43

(0.18, 0.67)43

0.93

0.52

STOP-Bang (2008),

Perioperative,

Canada48

Canada48

(0.84, 0.98)/

(0.43, 0.61)/

Persons with

0.43

0.90

cardiovascular

(0.33, 0.53)48

(0.79, 0.97)48

disease,
United States40
Sleep clinic,

0.87, 0.4340

Egypt43

PPV, Positive Predictive Value
NPV, Negative Predictive Value

0.98

0.87

(0.94, 0.99)/

(0.81, 0.91)/

0.03

0.20 (0.03,

(0.006, 0.19)43

0.71)43
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Table 4
OSA Screening and Assessment Practices in Primary Care
Author

Purpose

Participants

Measurement

Results

Non Experimental Designs
Cross-sectional Descriptive Studies
Alam et al.

Improve clinician

Persons with

STOP Bang and ESS

(2012). 56

knowledge and

severe mental

for OSA using STOP Bang; 20

United States

screening of OSA

illness in PC clinic

using ESS; 68 patients in high-

in persons with

(n=100)

risk group reported OSA was

severe mental

69 patients screened positive

never discussed by PCP

illness
BaHammam

Assess prevalence

Middle-aged

Berlin questionnaire

192 males were high risk.

et al.

of individuals who

Saudi males

Symptoms included;

(2008).53

were at risk of

(n=578), PC

BMI>30kg/m2 (n=153), HTN

Saudi Arabia

OSA

setting

(n=101), snoring (n=302),
apnea>3 times/week (n=30),
daytime sleepiness >once/week
(n=205), and sleeping while
driving (n=173).

BaHammam,

Assess the

Middle aged Saudi

Berlin questionnaire

156 women were high risk.

et al.

prevalence of

women (n=400),

Answers stratified

Symptoms included; HTN

(2009).55

symptoms and risk

PC setting

into three categories

(n=99), BMI > 30 (n=228),

Saudi Arabia

of OSA in women

of OSA severity

snoring (n=163),
apnea>3times/week (n=90),
day time sleepiness>1x/week
(n=210), falling asleep in car
(n=130).
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Burgess et

Determine

Adult patients at

ESS

Device results: AHI > 5

al. (2013).13

feasibility of using

high risk for OSA

(n=821), AHI > 15 (n=382),

Australia

an unattended 2-

(n=1,157) in

and AHI >30 (n=185). 81 were

channel device for

Family practice

unable to use accurately.

OSA screening in

clinics

a population of
high-risk patients
Haponik et

Determine how

PCP (n=20),

Simulated patients

3 interns inquired about sleep

al. (1996). 57

often sleep history

medical interns

(medical interns)

problems but questions were

United States

was obtained prior

(n=23), and

trained to volunteer

not asked regarding snoring,

to diagnosis.

interns instructed

sleep problems if

non-restorative sleep,

on sleep (n=22)

asked by the PCP

hypersomnia, and witnessed

during routine

apnea. 18 interns asked

health visit

questions more often.

Netzer et al.

Standardized

PC patients

Used Berlin

Participants in US had higher

(2003).54

survey of: a. PC

(n=6,223) in 40

questionnaire,

probability of OSA vs. Europe

United

patients, b.

offices and clinics

collected BMI, age,

and men > than women.

States,

frequency of

in US (n=26),

and sex.

Obesity rate was > in U.S vs.

Germany, &

symptoms/risk for

Germany (n=8)

Spain

OSA, c. composite

and Spain (n=6)

Europeans.

score for pretest
probability for
OSA
Used an investigator

3 PCPs asked ≥ three sleep

awareness level of

developed patient

questions, 3 asked two

PCPs during

questionnaire and

questions, 9 asked 1 question,

patient-physician

incorporated it into

15 asked no questions.

encounters

PCPs practice.

Reuveni et

Assess OSA

al. (2004).58
Israel

PCPs (n=30)
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Retrospective Studies
Bailes et al.

Discover what

Two samples a.

Sleep symptoms

PSG completers had higher

(2009).10

symptom

Older PC patients

checklist completed

AHI. Sleep clinic patients

Canada

presentation leads

(n=191);

by patients who stated

reported more sleep symptoms

to a successful

Sleep clinic

which symptoms they

and explained symptoms

sleep clinic

patients (n=138)

discussed with

directly.

referral.

physicians in past
year, followed up
with PSG referral.

Bartlett et al.

Describe

Adult PC patients

a. Mailed

2.9% of weighted respondents

(2008).11

prevalence/ risk

(n=1421, 18-24

questionnaire (sleep

reported visiting their doctor

Australia

factors for PC

year olds) and

behavior/ medication,

for insomnia and OSA. Older

consultations for

(n=1879, 25-65

and driver

patients reported more OSA

insomnia and/or

year olds).

safety/fatigue), b. 1

symptoms to PCP (n=133).

snoring/sleep

Question from

apnea

Pittsburg Sleep
Quality Index/ESS, c.
OSA/insomnia
questions, and d.
medical exam.

Kramer et al.

Evaluate percent

Patients (=69)

Investigator created

65 had OSA; of 63 patients

(1999).59

of patients referred

referred to hospital

worksheet

asked, 62 snored and 59

United States

by PCP for sleep

based sleep center

PSG

experienced daytime

studies;

by internists or

characterize

family practice

clinical features;
compare with
known OSA
patients.
Determine if PCP
asked questions on

sleepiness.
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a worksheet to
make OSA
diagnosis.
Sorscher

Determine

PC clinics (n=121)

Health history

57% of health history database

(2008).28

frequency of

and family

database

had no sleep health content.

United States

inquiry by PCPs

medicine

questionnaires

Two sites had sleep questions;

of unhealthy sleep

physicians

one site had a question about

patterns/symptoms

(n=935)

snoring.

on questionnaires.
Correlational Descriptive Studies
Demede et

Determine the

African American

Emanated from the

52 participants met criteria for

al. (2011).60

prevalence of RH

patients, PC

Metabolic Syndrome

RH. 80 screened as high risk

United States

and whether

setting (n=200)

Outcome Study.

for OSA. Patients with RH

patients are at

ESS via Apnea Risk

were at 2.5 times higher risk

greater risk for

Evaluation System

for OSA.

OSA.
Senthilvel et

Determine if PCPs

New adult patient

Cleveland Sleep

25 patients had ≥ one sleep

al. (2011).26

screen for sleep

evaluations

Habits Questionnaire,

symptom and limited sleep

United States

disorders during

(n=101)

Berlin questionnaire,

history. Questionnaires

clinical evaluation,

PC clinic at

ESS, and STOP

identified at risk patients more

compare to

tertiary care center

efficiently than PCPs. 9

validated

patients had sleep disorder

questionnaires.

documentation. 2 were
referred to sleep clinic.

Mixed Methods Study
Mold et al.

Determine

PC clinics (n=44),

a. semi structured

Of 662 younger patients, 299

(2011).62

proportion of PC

5 states, sleep

interviews with

discussed symptoms with

United States

patients at high

consultants (n=18)

clinicians/sleep

PCP. 283 older patients were

risk for OSA and

chart audits (n=

consultants, b.

at risk for OSA and 132

those who have

1744), patients

medical records, c.

discussed symptoms with

been diagnosed

(n=2091, n=1357

data from OSA

PCP. OSA prevalence among
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and treated as well

ages 30-64, n=734

patients, d. Berlin

the older adults was between

as methods used

age> 65)

questionnaire

12 and 25%.

by PCPs to
identify them.
Experimental
Design
Grover et al.

Determine: a. if

Adult patients

ROS forms and

At site 1, 92 patients reported

(2011).12

ROS form

(n=249)

Berlin questionnaire

sleep problems on ROS, 22

United States

identifies sleep

undergoing

complaints were documented.

complaints, b.

preventative

82 patients had increased risk

Frequency of

exams at family

of OSA. ROS responses were

PCPs investigating

practice clinics

57% sensitive and 73% specific

OSA complaints,

(n=2)

for increased OSA compared to

c. Prevalence of

Berlin questionnaire. At site 2,

patients at risk for

1of 20 sleep complaints were

OSA, d. How

documented.

accurately ROS
identifies OSA
Namen et al.

Estimate

Ambulatory care

Chart reminders

Chart reminders increased

(1999).63

frequency of

patients in

screened for a.

frequency of sleep histories,

United States

documented sleep

university,

hypersomnolence b.

from 6 to 29% over 3 years. 4

histories by

Physicians internal

difficulty sleeping c.

patients had sleep history

medical house

medicine clinic

interference with

recorded but had no impact

officers and to

(n=118)

daily functioning

management plan.

assess whether a
chart reminder
influenced their
performance
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Ball et al.

Enhance

Internal medicine

Sleep specialist

Referrals increased from 2 out

(1997).64

recognition of

patients (n=14330)

educated PCPs on use

of 752 cases to 294 out of

United States

sleep disorders by

of diagnostic

14,330 cases over 2 yrs. CPAP

PCPs; transfer

equipment. Chart

was started on 228 of patients.

diagnostic testing

reviews, patient

and care of

questionnaires, PSG

patients from

data, and specialized

tertiary care to the

reports were used.

community;
present PSG
experience
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Abstract
Background/Purpose: Portable sleep monitors (PSM) have increased in popularity due to
improvements in technology and accessibility. The American Academy of Sleep Medicine
established guidelines for obstructive sleep apnea (OSA) using PSM. A comprehensive sleep
evaluation and Level III PSM are required for OSA diagnosis. PSM must include least four
channels; two respiratory (respiratory movement and airflow), one cardiac (heart rate or
electrocardiogram), and oxygen saturation. Research studies using PSM have not consistently
reported procedures and methodological challenges. The first purpose of this paper was to
synthesize the literature on use of PSM in research of adults in terms of methodological
challenges, including: (a) participant sampling; (b) instrumentation issues; (c) clinical variables;
(d) data processing; and (e) patient acceptability. The second purpose was to identify
methodological strategies to use to standardize PSM information in research reports.
Methods: The search strategy included studies of participants undergoing sleep testing for OSA
using PSM. CINAHL, MEDLINE via PubMed, and Embase were search from 2000 to January
2016; some search terms used were “polysomnography”, “home”, “device(s)’, “level III’,
“obstructive sleep apnea”, “portable sleep monitors”, and “out of center testing”. Of the 371
articles retrieved, 338 articles were excluded because Level III PSM were not used; 33 articles
were included in this focused review.
Findings: The research articles were inconsistent in reporting methodological challenges. The
authors identified five criteria to examine. Participants usually included samples who had OSA or
were suspected of having OSA (n=20). Several different PSM (n=14) were used; the most
commonly reported instrumentation issue was device malfunction. Almost all studies reported
clinical variables (n=30). Data processing of the PSM data was discussed in the majority of the
articles (n=19). Few studies (n=6) reported information on patient acceptability.
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Conclusion: Ten methodological strategies are suggested for adoption when using PSM in
research. Future studies need to address the methodological challenges and adopt more consistent
procedures and reporting using these ten suggestions to advance knowledge.
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Methodological Strategies in Using Portable Sleep Monitoring in Research
Introduction
Obstructive sleep apnea (OSA) in adults has been increasing in prevalence over the last
two decades in the United States. The increase is attributed in part to the obesity epidemic
(Peppard et al., 2013). Estimates are that moderate to severe OSA, defined as an apnea hypopnea
index (AHI) ≥ 15 is present in 10% of men ages 30-49 years, 17% of men ages 50-70 years, and
9% of women ages 50-70 years. OSA contributes significantly to all-cause (Kendzerska et al.,
2014; Qaseem et al., 2014) and cardiac (Kendzerska et al., 2014) mortality. The gold standard for
OSA diagnosis is level 1 testing by laboratory polysomnography (PSG). During laboratory PSG
testing, surface electrodes are positioned to measure electroencephalography, muscle activity,
heart and respiratory physiology, and ocular movements (Marino et al., 2013). This type of
testing is recommended in patients with co-morbid conditions such as moderate to severe
pulmonary disease, neuromuscular disease, congestive heart failure, or suspected to have other
sleep disorders (central sleep apnea, periodic limb movement disorder, insomnia, parasomnias,
circadian rhythm disorders, or narcolepsy) (Collop et al., 2007). Because of the increase in OSA
prevalence, sleep laboratory and diagnostic services are in high demand and alternative methods
are needed to screen and diagnose sleep disorders.
In the late 1980’s, clinicians began to recognize the need for ambulatory sleep studies but
focused on arterial oxygen saturation (CleveMed & Cleveland Medical Devices Inc., 2016). The
first practice parameters for portable sleep monitors (PSM) were released in 1994 (Ferber et al.,
1994) and indications for PSG testing were published in 1997 (Chesson et al., 1997). At that time,
most devices measured snoring but did not meet diagnostic requirements for OSA. In 2000, the
Agency for Healthcare Research and Research Quality (AHRQ) reported results of a metaanalysis that stated broad use of PSM could not be supported due to insufficient evidence (Ross et
al., 2000). PSM were further developed to include oxygen saturation, heart rate, oral/nasal
airflow, respiratory effort and body position (CleveMed & Cleveland Medical Devices Inc.,
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2016). In 2006, the AASM released a statement recommending that physicians who use PSM
need to conduct a clinical assessment and a comprehensive patient evaluation. Further, PSM
could only be used by AASM-accredited sleep centers or board-certified sleep physicians and
treatment needed to be guided by the evaluation of study results and patient symptoms (American
Academy of Sleep Medicine, 2006; Collop et al., 2007). These recommendations encouraged
device manufacturers to develop PSM that met recommended criteria for screening and diagnosis
of OSA in home settings.
PSM has increased in popularity due to technological improvements and accessibility.
The Centers for Medicare and Medicaid (CMS) released standards for home testing requiring the
apnea hypopnea index (AHI) or respiratory distress index (RDI) as mandatory for OSA diagnosis
by PSM home testing (Department of Health and Human Services & Centers for Medicare &
Medicaid Services, 2013). AASM created a task force (2007) to develop guidelines for PSM.
These guidelines state that the diagnosis of OSA needs to be performed with a comprehensive
sleep evaluation and with monitors that have level III diagnostic capability, including at least four
channels; two respiratory variables (respiratory movement and airflow), cardiac measurement
(heart rate or electrocardiogram), and oxygen saturation. The level III monitors must display raw
data and allow for manual scoring, or editing of automatic scoring, by a sleep professional
because PSM can underestimate AHI levels compared to PSG (Collop et al., 2007).
PSM allow patients access to a less expensive diagnostic option that can be completed in
outpatient settings where sleep technologists are not present (Pereira, Driver, Stewart, &
Fitzpatrick, 2013). PSM are valuable diagnostic measures for OSA but are not without
disadvantages. Common issues with PSM include missing data due to equipment failure
(Nickerson et al., 2015; Pereira et al., 2013) and lower sensitivity and specificity levels compared
to PSG (Fredheim, Roislien, & Hjelmesaeth, 2014; Guerrero et al., 2014; Polese et al., 2013).
There has been significant night to night AHI level variability in mild versus moderate OSA,
when using PSM in home settings (Prasad et al., 2016). Researchers need to be knowledgeable of
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published literature using level III monitors. Knowledge from this focused review will inform the
readers regarding methodological challenges that are common with the use of the devices.
There are two main objectives for this manuscript. The first purpose was to synthesize the
literature of methodological challenges in using level III PSM in research in adult patents. The
second purpose was to identify methodological strategies to use to standardize PSM information
in research reports.
Methods
Studies that included participants undergoing home sleep testing for obstructive sleep
apnea diagnosis using PSM were identified by CINAHL, MEDLINE via PubMed, and Embase
from the year 2000 to January, 2016. The year 2000 was chosen because literature from Level III
PSM was not found prior to that date. Appropriate search terms for PSM were investigated by the
first author. A medical librarian assisted in searching the literature using the following search
terms: “polysomnography”; “home”; “device(s)”; “sleep disordered breathing”; “level III’;
“obstructive sleep apnea”; “sleep disordered breathing”; “portable sleep monitors”; “home sleep
testing devices for obstructive sleep apnea”; “out of center sleep testing”; “portable home sleep
testing”. Articles included in the review met the following criteria: (a) primary research using
PSM that reported methods, results, and findings, (c) Level III PSM examined, (c) sample size ≥
30 participants, and (d) published in the English language. Studies were excluded if: (a) pediatric
participants were included and (b) research was retrospective.
Search results
Of the 371 articles retrieved, 338 articles were excluded because Level III PSM were not
used. Relevant articles were reviewed by the medical librarian and the first author and were
subsequently verified by the co-authors. After implementing the exclusion criteria, 33 articles
were included in this focused review of PSM.
Selection of pertinent variables: The authors reviewed the 33 articles and identified five
challenges when using PSM in adult patients in research. These challenges included; (a)
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participant sampling; (b) instrumentation issues; (c) clinical variables; (d) data processing
methods; and (e) patient acceptability. Challenges were selected because they were the most
common themes described in the 33 articles. A review of the articles organized by these the
criteria is presented in Table 1.
Participant sampling. The sample and study settings were generally homogenous in
nature and were conducted in a variety of countries. Slightly less than half of the studies
[45%,(n=15)] had a sample size greater than or equal to 100 subjects (Abdel-Kader et al., 2012;
Aurora, Swartz, & Punjabi, 2015; Dawson et al., 2015; Dingli et al., 2003; Gonçalves et al., 2007;
Johansson, Alehagen, Svanborg, Dahlström, & Broström, 2012; Kuna, 2010; Masa et al., 2011;
Nakayama-Ashida et al., 2008; Pereira et al., 2013; Senchak, Frey, & O'Connor, 2012; Skomro et
al., 2010; Tedeschi et al., 2013; Tonelli de Oliveira et al., 2009; Weir et al., 2012). One-third
(n=11) of the studies in this literature review were conducted in the United States (Abdel-Kader
et al., 2012; Aurora et al., 2015; Dawson et al., 2015; Kuna et al., 2011; Lettieri, Lettieri, &
Carter, 2011; Michaelson, Allan, Chaney, & Mair, 2006; Nickerson et al., 2015; Reichert, Bloch,
Cundiff, & Votteri, 2003; Senchak et al., 2012; Su, Baroody, Kohrman, & Suskind, 2004; Weir et
al., 2012). Studies were conducted in 11 other countries, including: Argentina (Nigro, Malnis,
Dibur, & Rhodius, 2012), Brazil (Danzi-Soares et al., 2012; Gonçalves et al., 2007; Polese et al.,
2013; Santos-Silva et al., 2009; Tonelli de Oliveira et al., 2009), Canada (Driver et al., 2011;
Gjevre et al., 2011; Guerrero et al., 2014; Pereira et al., 2013; Skomro et al., 2010), China (H.
Chen et al., 2009; Yin, Miyazaki, & Ishikawa, 2006), Italy (Maestri, La Rovere, Robbi, & Pinna,
2011; Tedeschi et al., 2013), Japan (Nakayama-Ashida et al., 2008), Scotland (Dingli et al.,
2003), Spain (Masa et al., 2011), Sweden (Johansson et al., 2012; Zou, Grote, Peker, Lindblad, &
Hedner, 2006), Taiwan (Yeh, Lin, Chiu, & Bai, 2015), and Turkey (Yuceege, Firat, Demir, &
Ardic, 2013).
Most of the participants were sleep clinic patients who either had or were suspected of
having OSA [61%, (n=20)] (H. Chen et al., 2009; Dawson et al., 2015; Dingli et al., 2003; Driver
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et al., 2011; Gjevre et al., 2011; Guerrero et al., 2014; Kuna et al., 2011; Lettieri et al., 2011;
Masa et al., 2011; Michaelson et al., 2006; Nigro et al., 2012; Pereira et al., 2013; Polese et al.,
2013; Reichert et al., 2003; Santos-Silva et al., 2009; Skomro et al., 2010; Su et al., 2004;
Tedeschi et al., 2013; Tonelli de Oliveira et al., 2009; Yin et al., 2006). Twelve studies included
participants who had co-morbidities associated with OSA but met criteria for PSM (Abdel-Kader
et al., 2012; Aurora et al., 2015; Danzi-Soares et al., 2012; Gonçalves et al., 2007; Johansson et
al., 2012; Maestri et al., 2011; Nakayama-Ashida et al., 2008; Nickerson et al., 2015; Senchak et
al., 2012; Weir et al., 2012; Yeh et al., 2015; Yuceege et al., 2013; Zou et al., 2006).
Instrumentation issues. There were 14 different PSM used in the studies. However, three
models were used in more than half [55%, (n=18)] of the studies (Aurora et al., 2015; H. Chen et
al., 2009; Danzi-Soares et al., 2012; Dawson et al., 2015; Dingli et al., 2003; Gjevre et al., 2011;
Johansson et al., 2012; Kuna et al., 2011; Lettieri et al., 2011; Maestri et al., 2011; Nickerson et
al., 2015; Nigro et al., 2012; Polese et al., 2013; Santos-Silva et al., 2009; Senchak et al., 2012;
Skomro et al., 2010; Weir et al., 2012; Yin et al., 2006). Eleven PSM were used in the remainder
of the studies (Abdel-Kader et al., 2012; Driver et al., 2011; Gonçalves et al., 2007; Guerrero et
al., 2014; Masa et al., 2011; Michaelson et al., 2006; Nakayama-Ashida et al., 2008; Pereira et al.,
2013; Su et al., 2004; Tedeschi et al., 2013; Tonelli de Oliveira et al., 2009; Yeh et al., 2015;
Yuceege et al., 2013; Zou et al., 2006). Instrumentation related details included in these studies
were level of monitor, model, and manufacturer.
More than half [n=17, (52%)] of the studies reported problems with overnight collection
of sleep data such as: recordings less than minimum required time (Nakayama-Ashida et al.,
2008; Nickerson et al., 2015), lack of air flow recordings (Dingli et al., 2003; Nakayama-Ashida
et al., 2008; Tonelli de Oliveira et al., 2009; Yin et al., 2006), nasal cannula tube kinking (Driver
et al., 2011), incomplete pulse oximetry (Yin et al., 2006), battery/download failure (Driver et al.,
2011; Pereira et al., 2013; Polese et al., 2013; Reichert et al., 2003; Skomro et al., 2010), poor
participant compliance (Maestri et al., 2011; Reichert et al., 2003; Tonelli de Oliveira et al.,
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2009), overall device failure (Nakayama-Ashida et al., 2008; Tedeschi et al., 2013; Yeh et al.,
2015), underestimation of AHI severity compared to PSG (Lettieri et al., 2011), or unstated
reasons (Guerrero et al., 2014; Kuna et al., 2011; Yuceege et al., 2013).
Some studies [n=8, (24%)] reported engaging the participants in education of the PMS
prior to the release of the device for home testing (Dingli et al., 2003; Guerrero et al., 2014;
Nickerson et al., 2015; Pereira et al., 2013; Polese et al., 2013; Skomro et al., 2010; Yeh et al.,
2015; Yin et al., 2006). Understanding PSM instrumentation issues is critical to the reliability of
clinical variables. Data collected in a laboratory setting may have an environmental bias due to
sleep technician supervision; PSM device failures are more likely to be recognized and corrected.
Clinical variables. Clinical variables recorded and reported by PSM included AHI, RDI,
and ODI. AHI is the total number of apneas and hypopneas per hour of sleep. AHI levels range
from mild (≥ 5 and < 15), to moderate (15 ≥ and < 30), to severe (≥ 30) (Berry et al., 2014;
Epstein et al., 2009; Guilleminault et al., 2007). When using PSM, RDI is calculated as the
number of apneas and hypopneas divided by total recording time (Epstein et al., 2009). ODI is the
number of times per hour of sleep that the oxygen level in the blood drops by greater or equal to
3% from baseline (Berry et al., 2012).
AHI, RDI, and/or ODI were reported in 30 studies. The majority [(36%) (n=12] of
studies calculated and compared AHI levels from PSM to PSG (Abdel-Kader et al., 2012; H.
Chen et al., 2009; Danzi-Soares et al., 2012; Dingli et al., 2003; Guerrero et al., 2014; Masa et al.,
2011; Polese et al., 2013; Reichert et al., 2003; Santos-Silva et al., 2009; Skomro et al., 2010;
Tonelli de Oliveira et al., 2009; Yin et al., 2006). Four studies reported RDI and/or ODI (Dawson
et al., 2015; Driver et al., 2011; Tedeschi et al., 2013; Zou et al., 2006); and two studies compared
RDI and/or ODI from PSM to PSG (Pereira et al., 2013; Yuceege et al., 2013). Many studies
[n=10, (30%)] psychometrically tested PSMs in the sleep laboratory (H. Chen et al., 2009;
Dawson et al., 2015; Dingli et al., 2003; Driver et al., 2011; Michaelson et al., 2006; Polese et al.,
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2013; Reichert et al., 2003; Santos-Silva et al., 2009; Su et al., 2004; Tonelli de Oliveira et al.,
2009).
Each study had different research questions however, not all clinical variables were
compared to PSG. One study compared AHI and RDI levels from PSMs to a device made by
another manufacturer (Aurora et al., 2015). Another study compared AHI levels from a PSM to
the Berlin Questionnaire and the Epworth Sleepiness Scale to demonstrate feasibility in military
pre-deployment assessment (Senchak et al., 2012). Finally, one study compared AHI levels from
a PSM to acetylcholine receptor antibodies in patients with myasthenia gravis to examine
predictors for OSA (Yeh et al., 2015).
Data processing methods. According to the AASM, PSM must allow for the display of
raw data for manual scoring or be able to be edited by a trained sleep technologist. For diagnostic
purposes, review of the raw data must be completed by a certified sleep specialist or someone
who meets eligibility criteria for the sleep medicine certification exam (Collop et al., 2007).
In this review, 18 of the 33 articles (55%) discussed PSM data scoring methods; however,
one article did not state whether the data were scored automatically or manually (Kuna, 2010). A
few studies [n=4, (12%)] used physicians to manually interpret overnight PSM data (Gonçalves et
al., 2007; Guerrero, Masa, Embid, & Montserrat, 2014; Nigro et al., 2012; Tonelli de Oliveira et
al., 2009); in two studies (6%) physicians reviewed data after it was manually scored by a sleep
technician (Aurora et al., 2015; Gjevre et al., 2011). More commonly, studies used sleep
technicians (Abdel-Kader et al., 2012; Aurora et al., 2015; Driver et al., 2011; Guerrero et al.,
2014; Masa et al., 2015; Pereira et al., 2013; Santos-Silva et al., 2009), research personnel (Dingli
et al., 2003), employees of PM manufacturers (Michaelson et al., 2006; Su et al., 2004), or
unspecified persons (Johansson et al., 2012) to manually score data. Only 4 studies used
automatic scoring techniques to analyze the PSM data (C. Chen et al., 2015; Nigro et al., 2012;
Su et al., 2004; Yin et al., 2006).
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Patient acceptability. Six studies (18%) asked participants to evaluate use of PSM. Five
reported on ease of use and comfort of the PSM (Nickerson et al., 2015; Polese et al., 2013;
Senchak et al., 2012; Skomro et al., 2010; Yin et al., 2006). Three studies measured sleep quality
after using PSM (Gonçalves et al., 2007; Skomro et al., 2010; Yin et al., 2006) and two studies
asked their participants to use sleep diaries (Gonçalves et al., 2007; Skomro et al., 2010). Only
one study qualitatively measured how participants felt about PSM in terms of importance of OSA
testing, ease of use, comfort, and if the participants understood how the monitor worked
(Nickerson et al., 2015).
When analyzing research studies that used PSM as methodological instrument, it is
important to understand the study’s sampling, instrumentation issues, clinical variables, data
processing methods, and patient acceptability. These topics are vital considerations when
designing research studies using PSM.
Methodological Strategies for Using Portable Sleep Monitors in Research
There are many challenges when using PSM in research. Understanding and addressing
the challenges when designing a research study is vital to obtaining full sets of data and achieving
an accurate analysis of the clinical variables. Consistent standards of publishing can lead to easier
comparability of results across studies. Clinical guidelines for the use of PSM in the diagnosis of
OSA have been established (Collop et al., 2007) and should be used as a model when designing
validation studies. Based on findings from the review, this section identifies methodological
strategies to use to standardize PSM information in research reports (Table 2). Strategies were
organized into five areas: participant sampling, instrumentation issues, clinical variables, data
processing methods, and patient acceptability.
Participant sampling
Suggestion 1. Co-morbid conditions must be taken into account when selecting
inclusion/exclusion criteria. According to the AASM task force, PSM testing is not appropriate
in patients with significant co-morbid conditions (moderate to severe pulmonary disease,
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neuromuscular disease, or congestive heart failure) due to the degradation of data accuracy.
Likewise, PSM testing is not recommended in patients suspected of having other sleep disorders
(central sleep apnea, periodic limb movement disorder, insomnia, parasomnias, circadian rhythm
disorders, or narcolepsy) (Collop et al., 2007). Patients with these co-morbid conditions must
receive laboratory PSG testing under direct supervision of a certified sleep technician in order to
establish an OSA diagnosis.
Suggestion 2. Instruct participant on his/her role in data collection, such as wear
time and recordings on specific days of the week. Each individual has a unique sleep schedule
and patterns may vary depending on weekdays, weekends, and work schedules. Some participants
may be hesitant to engage in research studies that include PSM because they have busy work and
life schedules and changes in sleep habits may affect their level of daytime functioning. Some
participants may engage in more social activities on the weekend that may include alcohol
consumption, which increases the likelihood of pharyngeal collapse and apneic/hypopneic
episodes. Consistency in assigning the same days, when feasible, is suggested to reduce
variability and the length of recording time needed to analyze sleep data. The researcher is
responsible to explain the importance of adequate wear time to reduce the amount of missing
data.
Instrumentation issues
Suggestion 3. Monitors should be at least level III and include a minimum of four
channels. Portable sleep testing has evolved over time and involves a wide range of available
technology. Types of testing can range from the most thorough laboratory PSG (level I) which
typically records nine physiologic channels (electroencephalogram, electrooculogram,
electrocardiogram, chin electromyogram (EMG), limb EMG, respiratory effort at
thorax/abdomen, airflow from nasal cannula, pulse oximetry, and ability to monitor continuous
positive airway pressure or bi level positive airway pressure) to the least thorough unattended
portable device, with two channels (oxygen saturation and airflow) (CleveMed & Cleveland
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Medical Devices Inc., 2016). Monitors used in research should be at least level III capabilities
with at least four channels, including: two respiratory variables (respiratory movement and
airflow), cardiac measurement (heart rate or electrocardiogram), and oxygen saturation. Some
PSM have features that record snoring, detect light, or can sense changes in body position;
however, these channels are not mandatory for diagnostic testing (CleveMed & Cleveland
Medical Devices Inc., 2016; Collop et al., 2007).
Suggestion 4. Cost of PSM supplies should be considered when designing a study.
For research purposes, most PSM are available for rent (policies and cost differ between
suppliers/ companies/ models / manufactures). Along with funding for the sleep monitor,
researchers must take into account the purchase of the sensors that attach to the device, which
vary depending on the model (typically nasal cannulas, oxygen probes, batteries, abdominal
belts). All PSM used in the research study should be of the same type and model to ensure the
validity and reliability of the data.
Clinical variables
Suggestion 5. AHI or RDI must be reported as the outcome variable from the PSM.
Reporting of the AHI or RDI after PSM is mandatory for OSA diagnosis and reimbursement by
Medicare & Medicaid standards; ODI may be reported but is not considered diagnostic for OSA
(Department of Health and Human Services & Centers for Medicare & Medicaid Services, 2013).
Suggestion 6. Provide definition(s) of outcome variable(s). It is important for
researchers to provide clear operational definitions of the variables being measured in order to
compare findings and clinical applications. Providing definitions for AHI, RDI, or ODI orients
the reader to the physiological importance of the data.
Data processing methods
Suggestion 7. Researchers must determine how PSM data will be stored, analyzed,
and reported when designing the study. Many models of PSM may be used repeatedly, as the
data can be stored, the device cleaned, and released quickly to a new participant. One of the
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challenges is determining how data will be stored after use and how/who will analyze it. Prior to
beginning the study, researchers need to identify secure places for data storage and accessibility
according to IRB regulations/criteria. Once the PSM data is downloaded and stored in a secure
area, many manufactures provide programs that allow for automatic or manual scoring. AAMS
states that the PSM must display raw data and allow for manual scoring or editing of automatic
scoring by a sleep professional (Collop et al., 2007). Automatic scoring is completed by
downloading the PSM data to the manufacturer’s software program that analyzes the data.
Manual scoring must take place by a sleep professional who has been trained in scoring raw sleep
data (sleep technologist or board certified sleep physician) (Collop et al., 2007), which can be
labor intensive and require additional fees for researchers. Measuring and reporting interrater
reliability is valuable when using more than one professional to manually score in order to assure
concordance among raters (Hallgren, 2012).
The researchers must describe methods used for data entry, cleaning of data, and use of
statistical software. Data analysis methods and the statistical analysis package should be reported
to allow for comparisons between studies. Psychometric analysis of PSM should be conducted in
comparison to PSG, the gold standard of OSA diagnosis. Reporting correlational analyses as well
as sensitivity, specificity, positive predictive value, and negative predictive value are necessary
when conducting validity testing. Percentage of missing data from equipment failure, inadequate
wear time, or participant refusal must be reported.
Suggestion 8. Report the PSM by model, manufacturer, and use of software. PSM
data recording and analysis may vary between manufacturers. Selecting a PSM should be based
on the aims and methodology of the study. It is important to report the specific PSM model,
manufacturer, and location, as well as the software used to provide transparency of data collection
and analysis methods.
Patient acceptability
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Suggestion 9. Provide PSM education using return demonstration methods.
Participants need to receive in-depth training on the use of the PSM to obtain complete data.
Researchers should have a PSM in their possession for demonstration purposes when participants
are being enrolled into a study. The participant needs to understand how to use the PSM prior to
enrollment. The researcher should demonstrate application of the sensors and the monitor on the
participant so they know how the device should be worn during sleep. The researcher should
request a return demonstration of how to apply the device and the how it is turned on and off.
Participants should be told to feel free to ask questions about application or operation of the
device.
Suggestion 10. Provide take-home PSM education materials that discuss possible
technical difficulties and trouble-shooting techniques and research assistant contact
information. Researchers need to be aware of technological difficulties that participants
experience once they use the PSM at home. Many manufacturers have developed troubleshooting and educational handouts that need to be given to participants to take home. It is
important to provide information on how to contact a research assistant with questions when the
PSM is being applied. This will allow participants to contact a staff member with questions and to
decrease amounts of missing data from insufficient wear time or incorrect application of the
PSM.
Conclusion
Many methodological challenges accompany the use of PSM in research. This review
examined published research literature of PSM use and strategies used in research. The most
consistent strategy described in these studies was the reporting of clinical variables. The majority
reported AHI and less commonly RDI. Data processing was reported in most manuscripts and
many used sleep professionals to complete manual scoring. The most commonly reported
instrumentation issue was device malfunction resulting in loss of data. Only one-third of the
studies included participants who were not enrolled from a sleep clinic. Few studies reported
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using patient acceptability methods. None of the research articles addressed all five
methodological strategies developed by the authors.
Sampling needs to be considered when designing studies using PSM. Participants’
comorbid conditions should be taken into account as well their ability to complete data collection.
Understanding the technological difficulties that can occur with PSM, such as device failure or
problems with sensor misplacement, is needed because data inaccuracies in overnight sleep
testing affect the analysis, reliability, and validity of the results, especially when compared to
PSG. Researchers must determine whether data will be interpreted automatically or manually and
will need to arrange for a qualified sleep professional to interpret findings accordingly. Finally,
understanding the patient’s perspective of PSM is important to achieving complete data. PSM can
be perceived as cumbersome to wear during sleep and may cause anxiety for participants if they
are not taught and involved in interactive teaching how to use the device.
Ten methodological strategies are suggested for adoption when using PSM in research.
Future studies need to address the methodological challenges and adopt more consistent
procedures and reporting using these ten suggestions to advance knowledge. The frequency of use
of PSM in the clinical setting has increased because of the technological advancement and
availability of the devices. Even though laboratory PSG continues to be the gold standard of OSA
diagnosis, PSM are used for OSA screening and diagnosis in outpatient settings. The body of
knowledge regarding PSM in research is growing rapidly but there has been no report discussing
methodological strategies for PSM use in research outside a sleep laboratory. Awareness and
action regarding these challenges will increase the validity of the data presented in research
articles.
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Focused Review of Methods Included in Research of PSM
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2. Instrumentation
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Abdel-Kader et al.
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Masa et al. (2011)
Michaelson et al.
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Nakayama-Ashida
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Nigro et al. (2012)
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3. Clinical
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Skomro et al. (2010)

X

X

Yin et al. (2006)
Yuceege et al.
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Zou et al. (2006)
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X
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Polese et al. (2013)

Su et al. (2004)
Tedschi et al. (2013)
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Table 2
Methodological Strategies to use to Standardize PSM Information in Research Reports
Sampling
Co-morbid conditions must be taken into account when selecting inclusion/exclusion criteria.
Instruct patient on his/her role in data collection, such as wear time and recordings on specific days of the week.
Instrumentation Issues
Monitors used should be at a least level III and include a minimum four channels
Cost of PSM supplies should be considered when designing a study
Clinical Variables
AHI or RDI must be reported as the outcome variable from the PSM.
Provide definition of outcome variable
Data Processing Methods
Researchers must determine how PSM data will be stored, analyzed, and reported when designing the study.
Report PSM by model, use of software, and manufacturer
Patient Acceptability
Provide PSM education using return demonstration methods
Provide take-home PSM education materials that discuss possible technical difficulties and trouble-shooting
techniques and research assistant contact information.
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Abstract
Background: Obstructive Sleep Apnea (OSA) contributes to all-cause and cardiac mortality but
there are no current guidelines for OSA screening in outpatient settings due to inconsistent
measurement psychometric properties. An American Academy of Sleep Medicine task force is
focusing on improving detection and categorization of OSA symptoms and severity to promote
screening, assessment, and diagnosis of the disorder. The purpose of this study was to identify the
psychometric properties of three self-report OSA screening measures (Berlin, Epworth Sleepiness
Scale (ESS), STOP Bang) and an objective portable sleep monitor (PSM) compared to AHI
(apnea-hypopnea index) levels (≥5, ≥ 15, and ≥ 30) from polysomnogram (PSG).
Methods: A methodological design was used. Patients referred to a sleep specialist for an OSA
consultation were recruited and enrolled at initial sleep evaluation. Participants completed the
three OSA self-report screening measures and those participants who met inclusion criteria were
sent home with a PSM for one night measurement. Automatic scoring was used. PSGs were
ordered by the physician and AHI results were obtained from the medical record.
Results: Participants (N=170) were enrolled (88 male, 82 female; age 54.5, SD 5.0 years).
Almost all participants (168) completed the self-report OSA screening measures, approximately
half (91) completed PSM measurement, and the majority (142) completed laboratory PSG. The
STOP Bang had the highest levels of sensitivity; the ESS had the lowest. The ESS had the highest
specificity and reliability levels; the STOP Bang had the lowest. The PSM measure had the
highest positive predictive value (PPV) but when AHI was ≥ 30, the PPV was unacceptable. The
PSM measure had the strongest psychometric properties of the screening measures.
Conclusions: The STOP Bang was the preferred self-report OSA screening measure because of
its high levels of sensitivity. A positive STOP Bang warrants assessment for OSA. The ESS is the
least desirable screening measure. If a patient qualifies, further screening with a PSM is indicated.
PSM measurement consistently predicted the presence of OSA but at the expense of low
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sensitivity at AHI levels ≥ 30. PSM results can guide the referral process from primary or
specialty clinicians to sleep specialists.
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Psychometric Properties of Obstructive Sleep Apnea Screening Measures in
Patients Referred to a Sleep Clinic
Introduction
Obstructive sleep apnea (OSA) is a sleep-related breathing disorder that significantly
contributes to all-cause (Kendzerska et al., 2014; Qaseem et al., 2014) and cardiac mortality
(Kendzerska et al., 2014). The estimated prevalence rate of moderate to severe OSA in the United
States is approximately 10% to 20%. The rate is thought to be influenced by the obesity epidemic
and to have increased dramatically over the past two decades (Peppard et al., 2013).
Repetitive obstructive breathing events are caused by increased volume in upper airway
structures (Peppard et al., 2009) and result in intermittent hypoxia, activation of oxygen free
radicals, and an oxidative stress response. An inflammatory process is believed to damage the
vascular endothelium, leading to atheroma formation and vascular events (Almendros et al.,
2011; Xie et al., 2013). The long-term results of these physiological events are development of
hypertension, tachyarrhythmias (Bradley & Floras, 2003; Kohli et al., 2011), reduced left
ventricular stroke volume (Yumino et al., 2013), stroke (Lipford et al., 2015), cognitive
impairment (Aaronson et al., 2015), and insulin resistance (Heffner et al., 2012). Thus, OSA is a
large public health burden (D. J. Gottlieb et al., 2013; Kendzerska et al., 2014).
Despite the evidence, OSA screening measures are not used consistently in primary care
or specialty clinics to guide the patient referral process. An American Academy of Sleep
Medicine (AASM) task force recently released quality measures for the care of adult patients with
OSA. The first quality measure outcome listed was to improve detection and categorization of
OSA symptoms and severity (Aurora et al., 2015). The United States Preventative Services Task
Force released final recommendations for OSA screening in adults; more research needs to be
conducted in terms of OSA screening and health outcomes, the accuracy of multi-step screening
in outpatient populations, and home based sleep testing (U.S. Preventative Services Task Force,
2016).
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It is clear that the United States’ health care system needs to develop a more streamlined
approach to OSA screening, assessment, and diagnosis. The current gold standard for OSA
diagnosis is the overnight laboratory polysomnogram (PSG) with a sleep technologist in
attendance. Surface electrodes are applied to the patient’s body prior to falling asleep to measure
electroencephalography, electromyography, cardiac rhythms, respiratory effort, and ocular
movements (Marino et al., 2013). Data gathered from the laboratory PSG are analyzed by a
physician trained in interpreting PSG results; apnea hypopnea index (AHI) levels (≥ 15) is
diagnostic for OSA. Given the labor-intensive nature of PSG testing and the limited number of
sleep laboratory resources, it was necessary to develop a less expensive option for OSA
screening, assessment, and diagnosis in outpatient populations.
The increased need for PSG services has encouraged sleep experts and monitor
manufacturers to develop PSM that allow patients to be screened or diagnosed with OSA in home
settings. A recent trend in OSA diagnosis includes the use of level III portable sleep monitors
(PSM) that record oxygen saturation, heart rate, and breathing patterns (apneas, hypopneas,
snoring, probability of Cheyne-Stokes breathing) (CleveMed & Cleveland Medical Devices Inc.,
2016). PSM that can be used for diagnostic purposes are of level III capabilities and have four
channels. The Centers of Medicare and Medicaid have released standards in home testing.
Reporting the AHI or respiratory distress index (RDI) after PSM is mandatory for OSA diagnosis
for home testing (Department of Health and Human Services & Centers for Medicare & Medicaid
Services, 2013).
There are no current guidelines for screening for OSA in outpatient settings; thus,
screening is performed inconsistently. The screening measures that are often used to detect OSA
are the Epworth Sleepiness Scale (ESS) (Johns, 1991) and the Berlin Questionnaire (Berlin)
(Netzer et al., 1999). The STOP Bang questionnaire has been used to predict airway obstructive
events in pre-operative patients in the acute care setting but more outpatient validation studies are
needed (Chung et al., 2008a).
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The knowledge gained from this study contributes to science by identifying the most
sensitive and specific OSA measures to use in screening. Therefore, in patients who have been
referred to a sleep specialist for a sleep disordered breathing evaluation, the purpose of this
methodological study was to evaluate the psychometric properties of three self-report OSA
screening measures (Berlin, Epworth Sleepiness Scale, STOP Bang) and an objective PSM
(ApneaLink AirTM; ResMed, San Diego, CA) compared to AHI levels from PSG.
Methods
Research Design
The design was a methodological study. The study was approved by the University
Institutional Review Board.
Sample/Setting
A convenience sample of adults who were being evaluated for OSA (n=173) were invited
and (n=170) were recruited from a Midwestern sleep clinic over a five month period. The clinic
has nine physicians specializing in pulmonary and critical care medicine; seven are board
certified in sleep medicine and averages 20-25 new consultations for OSA a week.
Inclusion/Exclusion Criteria
Inclusion criteria for the study were: (a) patients ≥ 19 years old scheduled for OSA
consultation at sleep clinic, and (b) able to communicate in writing and over the telephone in
English.
Patients were excluded from the study if they: (a) were using a continuous positive
airway pressure (CPAP) device, (b) could not undergo PSG, (c) were unable to repeat back
procedures of the research study, and (d) were pregnant.
Exclusion criteria for collecting PSM data per AASM’s recommendations were: (a)
persons with significant comorbid conditions such as moderate to severe pulmonary disease,
neuromuscular disease, or congestive heart failure; or (b) suspected to have other sleep disorders
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including central sleep apnea, periodic limb movement disorder, insomnia, parasomnia, circadian
rhythm disorders, or narcolepsy (Collop et al., 2007).
Conceptual Framework
The conceptual framework used was adapted from a framework of relationships between
OSA and cardiovascular risk factors (Kohli et al., 2011) (Figure 1). This framework emphasizes
the need for screening, assessment, and diagnosis of OSA, which is the main-focus of this study.
The current practice model for screening and assessment of OSA is inconsistent. The second
component of this framework displays the cardiovascular risk factors, consequences, and diseases
that result from untreated OSA. Cardiovascular risk factors that were measured in this study
include elevated heart rate, blood pressure, and decreased myocardial oxygen delivery. This
model informs the study by emphasizing the importance of identifying measures that are highly
predictive of OSA.
Measurements
Several OSA screening measures have been developed to aid health care providers in
quickly screening patients for moderate to severe OSA in a variety of health care settings
(Abrishami et al., 2010; Ramachandran & Josephs, 2009; Silva et al., 2011). The OSA screening
measures selected in this study were Berlin, ESS, STOP Bang and the ApneaLink Air for
comparisons with AHI levels from PSG. The self-report OSA screening measures were chosen
because they are most commonly used. This section will describe these measures and present
content regarding the validity testing used to determine the psychometric properties of the
measures.
Berlin. The measure (Netzer et al., 1999) was developed by primary care and pulmonary
care physicians to predict the presence of OSA in patients. The measure has three symptom
categories and a total of 11 items. The first category has five unique questions concerning
frequency (rare to often) of snoring and apneas while sleeping. The second category has four
unique questions concerning daytime sleepiness with a question about sleepiness while driving. A
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score is positive for category 1 and 2 when a patient selects two responses from the top levels.
The third category has two questions. A positive response indicates a patient has high blood
pressure (>140/90 mmHg) or a BMI > 30kg/m2. The screening measure was considered negative
if none or one of the categories were positive and positive if two or three of the categories were
positive. The Berlin has a Flesch-Kincaid reading level of 4th grade, which is acceptable as it is
lower than the recommended 5th grade level (Tarescavage & Ben‐Porath, 2014).
When the measure was compared to home PSG, internal reliability testing showed
category 1 (snoring) was high (α=0.92) but Category 2 (daytime sleepiness) was low (α=0.63).
When the question about sleeping behind the wheel was excluded, the category 2 Cronbach alpha
level increased (0.86) (Netzer et al., 1999). Chung et al. (2008b) and El-Sayed (2012) found the
Berlin had higher levels of sensitivity (0.79, 0.95) than specificity (0.51, 0.07) but Netzer et al.
(1999) reported inconsistent results (sensitivity 0.54, specificity 0.97).
Epworth Sleepiness Scale (ESS). The measure (Johns, 1991) was developed as a simple
questionnaire to quantify the level of daytime sleepiness in adults and is a brief, self-administered
scale that asks the subject to rate their level of sleepiness (0= none to 3 =high chance of dozing)
during eight daily activities. Once completed, the researcher calculates the sum of the eight
questions and the higher the sum, the higher the sleep deficit (0-24). A score of 16 or more
indicates a high level of daytime sleepiness (Johns, 1991) and is considered a positive screen. The
ESS has been shown to have high internal consistency values (α=0.88) (Johns, 1992).
Inconsistent sensitivity (0.76, 0.39) and specificity (0.48, 0.71) values have been reported (ElSayed, 2012; Silva et al., 2011). El-Sayed (2012) stated that the ESS has high PPV (0.91) with
lower NPV (0.23). The ESS has a Flesch-Kincaid reading level of 8th grade, which is higher than
the recommended 5th grade level (Tarescavage & Ben‐Porath, 2014).
STOP Bang. The measure is comprised of eight Yes/No questions. The questions are
arranged in the acronym of STOP Bang (snoring, tiredness, obstruction, blood pressure, BMI,
age, neck circumference (>17 inches for male, >16 inches for female), gender (male/female).
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With every “yes” the person scores one point for that question. The scores can range from 0 to 8,
with greater or equal to three equating to a positive screen (Chung et al., 2008a). Higher scores
achieved on the measure have been shown to correlate with the individual’s OSA severity (Chung
et al., 2008b). In sleep patients, El-Sayed (2012) reported that the sensitivity of the measure
stayed consistent between the STOP (0.95) and the STOP Bang (0.98), but Silva et al. (2011)
reported an improvement (0.62 to 0.87). The measures PPV (0.52, 0.87) and NPV (0.9, 0.2) were
inconsistent between studies (Chung et al., 2008a; Chung et al., 2008b; El-Sayed, 2012). The
STOP Bang has a Flesch-Kincaid reading level of 3rd grade, which is an acceptable (Tarescavage
& Ben‐Porath, 2014).
ApneaLink AirTM. The ApneaLink Air (ResMed, San Diego, CA) is a level III, four
channel, overnight PSM that is prescribed by a health care provider. The device monitors (a)
oxygen saturation, (b) heart rate, and (c) breathing patterns (apneas, hypopneas, snoring,
probability of Cheyne-Stokes breathing). An AHI level of ≥ 15 on the ApneaLink Air was the
indicator of a positive screen for OSA in this study (Collop et al., 2007). Fredheim, Roislein,
Hjelmesaeth (2014) studied an ApneaLink monitor over two nights in morbidly obese patients.
The average sensitivity (94%) and specificity (94%) of the instrument were high at an AHI level
≥ 15 and the night-to-night variability of the instrument was almost zero. Erman et al. (2007)
compared the original ApneaLink monitor to laboratory PSG and reported acceptable sensitivity
(76%) and specificity (94%) levels at AHI of ≥ 15 events per hour. Ragette, Weinreich, Teschler
(2010) conducted a study with similar methods as Erman et al (2007), but reported higher
sensitivity (92%) and slightly lower specificity (88%) levels. Night to night variability has been
documented in PSM mild to moderate OSA (Prasad et al., 2016).
Polysomnography (PSG). Laboratory PSG under supervision of a sleep technician is the
gold standard for OSA diagnosis. Surface electrodes are applied to the patient’s body prior to
falling asleep to measure electroencephalography, muscle activity, heart and respiratory
physiology, and ocular movements (Marino et al., 2013). An AASM task force (2012) defined
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apnea events in adults as “a drop in the peak signal excursion by ≥ 90% of pre-event baseline
using an oronasal thermal senor (diagnostic study), positive assisted pressure (PAP) device flow
(titration study), or an alternative apnea sensor, for ≥ 10 seconds” (p.606). Hypopnea events in
adults were scored when “the peak signal excursions drop by ≥ 30% of pre-event baseline using
nasal pressure (diagnostic study), PAP device flow (titration study), or an alternative sensor for ≥
10 seconds in association with either ≥ 3% arterial oxygen desaturation or an arousal (Berry et al.,
2012). The severity of OSA was defined by AASM as “an individual’s Apnea Hypopnea Index
(AHI), which indicates how many times an hour the patient experiences obstructive events”
(Epstein et al., 2009). AHI levels range from mild (≥ 5 and < 15), to moderate (15 ≥ and < 30), to
severe (≥ 30) (Berry et al., 2014; Epstein et al., 2009; Guilleminault et al., 2007). The AHI levels
are an indirect measure of myocardial oxygen delivery. Laboratory PSG data were analyzed by a
physician trained in interpreting results. AHI levels ≥ 15 from PSG were considered positive in
this study as it is considered to be clinically significant when treating OSA.
Procedures
Patients were first approached by a staff member of the clinic and asked if they were
interested in speaking to a researcher about a study. If they agreed, patients were interviewed to
assess their eligibility to participate in the study by the first author. After the informed consent
process, participants completed a demographics section and three self-report OSA screening
measures: (a) Berlin (Netzer et al., 1999), (b) ESS (Johns, 1991), and (c) STOP Bang (Chung et
al., 2012).
Next, participants were taught how to use the PSM at home and were asked to enact a
return demonstration. They were asked to wear the Level III PSM for one full night. The
equipment for the PSM consisted of an oxygen finger probe, a nasal cannula pressure sensor, and
a thoracic band. Participants were instructed to attach the device when they were ready to go to
sleep, turn it on, place tape over the finger probe to secure it, and to turn it off once they woke up.
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After completing home sleep testing, most participants underwent PSG testing as
prescribed by their sleep physician. PSGs were either conducted as diagnostic or split-night sleep
studies. Some participants completed diagnostic PSG testing in their home, per insurance
requirements. For split-night sleep studies, data were interpreted from the diagnostic portion of
the study and not after application of OSA treatment. The PSGs were first scored by a sleep
laboratory technician and then reviewed and dictated by a board certified sleep physician.
Data Analysis
Data from the self-report screening measures (Berlin, ESS, and the STOP Bang) were
scored by the first author. There were minimal missing data on OSA screening measures. Nonparametric statistics were used to examine clinical utility data (time to score and appropriateness
of the measures). Data collected from the ApneaLink Air were analyzed by the ResMed
computerized scoring program. The findings of the four OSA screening measures were compared
to PSG. Data from PSG testing were first scored by a sleep laboratory technician and interpreted
by a board certified sleep physician. AHI levels were divided into three severity categories; mild
(≥ 5) moderate (≥15), and severe (≥30). In order to assess the impact of different cut-points that
have been considered in the literature, psychometric testing for each OSA screening measure was
completed at each AHI level (≥5, ≥ 15, and ≥ 30) for sensitivity, specificity, positive predictive
value (PPV), and negative predictive value (NPV). Screening measures and PSG data were stored
on a secure server. After data were collected and entered into an excel spreadsheet, data were
cleaned and checked for outliers and missing data. Data were then analyzed using IBM SPSS
statistical software, version 23.
Reliability testing was conducted using KR-20 values for the Berlin and the STOP Bang
measures. Cronbach's alpha reliability was assessed on the Epworth Sleepiness Scale.
Table 1 displays several types of validity testing that were used to calculate psychometric
properties of the OSA screening measure. The types of validity testing included calculation of
criterion validity (predictive and concurrent) and construct validity (convergent and known
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groups testing) for each of the OSA screening measures. Predictive validity testing (sensitivity,
specificity, positive predictive value, and negative predictive value) compared the OSA screening
measure scores to the AHI levels from PSG. Concurrent validity testing compared a positive and
negative screen to AHI levels from PSG. Convergent validity testing correlated each OSA
screening measures’ score against the other measures. Known groups testing compared OSA
measure scores in patients who did/did not have AHI ≥ 15 from PSG.
Bivariate concurrent, convergent, and known groups validity testing were completed
between the OSA screening measures. Independent sample t-tests were used for known-groups
validity analysis to compare the ESS, STOP Bang, and ApneaLink Air to AHI levels ≥ 15 from
PSG. Because the Berlin has dichotomous scoring in the third category, chi-squared testing was
used to compare the screening measure to AHI level ≥ 15 from PSG. Phi correlations were used
for concurrent and convergent validity analysis, to correlate positive and negative screens on
OSA screening measures compared to each other and AHI levels from PSG. Bivariate scoring
was used to test the validity of the measures compared to each other and using AHI ≥ 15 cut
point. Spearman’s rho correlational analyses were conducted between the continuous scores of
the OSA screening measures and AHI levels from PSG.
To assess measurement agreement of AHI levels from ApneaLink Air and PSG, a BlandAltman plot of agreement was constructed (Bland & Altman, 1986). A single sample t-test of
differences and regression analyses predicting differences from means were subsequently
conducted to assess if AHI levels deviated from the null hypotheses of agreement and no
proportional bias.
Results
This methodological study recruited 170 participants, 88 male and 82 female with an
overall mean age of 54.5 (SD=15.0 years). All participants completed the Berlin Questionnaire
and STOP Bang; almost all (n=168) completed the ESS. The majority of participants scored
positive for OSA on the Berlin (n=143, 84%) and STOP Bang (n=149, 88%); less than one-
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quarter scored positive on the ESS (n=37, 22%). The Berlin Category 1, questions 2 (n=21), 3
(n=18), and 4 (n=11) had the most amount of missing data because questions required
information from a bed partner for a participant answer (i.e. loudness, frequency, and annoyance
of snoring). The median score on the ESS was 10 (SD=5.4, range 1-24). The STOP Bang median
score was 4 (SD =1.7, range 1-7). The average time to score the Berlin was 20 seconds but the
measure was difficult for people to complete if they slept alone. The average time to complete the
ESS was 4.6 seconds and the STOP Bang was 3.5 seconds.
Only about half of the participants (n=91, 53%) met criteria for home sleep testing per
AASM guidelines (Collop et al., 2007). Almost all participants who met criteria completed sleep
testing in their homes (n=87, 96%). However, 10 (15%) of the recordings were invalid due to
insufficient data such as wearing less than two hours (n=8) and equipment failure (n=2). The
PSM AHI levels ranged from 0 to 139 with a mean of 21.9 (SD=27.6).
A total of 142 (84%) participants completed physician ordered PSG; AHI levels ranged
from 0 to 113.7 with a mean of 20.7 (SD=24.5). Slightly greater than half of the participants who
underwent PSG testing (n=77, 54.2%) had AHI levels < 15. Therefore, AHI levels from PSG
were positively skewed indicating an abnormal distribution, with most participants having lower
OSA severity. Outliers (n=12) were found at high (≥ 60) AHI levels. No cases were deleted from
the database. Less than half participants completed all OSA screening measures and PSG (n=73)
(Table 2).
Reliability testing was conducted on the OSA screening measures. Both the Berlin
(KR20=0.661) and STOP Bang (KR20=0.407) measures showed low reliability but the ESS’s
Cronbach’s alpha was high (α= 0.845).
Table 3 displays the psychometrics of each OSA screening measure at AHI levels (≥5, ≥
15, and ≥ 30). For a PSG AHI cut point of ≥5 events per hour, the Berlin and STOP Bang had
high sensitivity levels but the ESS had the highest specificity level. The ApneaLink Air had the
highest positive predictive value (PPV) and the ESS had second highest. These levels are
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acceptable for psychometric testing. All negative predictive values (NPV) were low and
unacceptable for psychometric testing.
At a PSG AHI cut point of ≥ 15 events an hour, the Berlin and the STOP Bang again had
high sensitivity levels. The ApneaLink Air and ESS had similar acceptable specificity levels. The
ApneaLink Air had the highest PPV and NPV and both levels were acceptable.
At a PSG AHI cut point of ≥ 30 events an hour, the Berlin and STOP Bang repeated their
high sensitivity levels. The ApneaLink Air and the ESS again had high specificity levels. The
ApneaLink Air had the highest PPV. The STOP Bang had the highest NPV.
Table 4 shows results of other validity testing, including PSG included known-groups,
concurrent, and convergent testing. Known groups validity testing was completed with chi-square
testing for the Berlin (χ2 3.346, p=0.067). The independent sample t-test showed there was a
significant difference in positive (M=5.12, SD=1.61) and negative (M=4.22, SD=4.55) scores for
the STOP Bang [t (140) = 3.40, p = .001] and a significant difference in positive (M=38.37,
SD=30.75) and negative (M=9.0, SD=17.25) AHI levels for the ApneaLink Air [t (58.50) = 5.12,
p = .000]. The ESS did not show a significant difference in positive and negative scores [t (138)=
1.46, p = .146].
Phi-correlations were used to conduct bivariate concurrent and convergent validity
testing. A significant but moderate correlation was detected between positive and negative AHI
levels ≥ 15 from the ApneaLink Air and PSG (r=0.656, p=.01). A significant correlation was
detected between positive and negative scores on the Berlin and STOP Bang (r=.375, p=.01).
Spearman’s rho correlational analysis was completed between the continuous variables of
the OSA screening measures and AHI levels from PSG. All OSA screening measures had a
significant correlation to AHI from PSG (p ≤ 0.05); however, the ApneaLink Air and the STOP
Bang had the highest correlations. ApneaLink Air AHI levels had a strong linear relationship
(r=0.750, p=0.01) and the STOP Bang had a moderate linear relationship (r=.327, p=.01) with
AHI levels from PSG.
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Figure 1 shows a Bland-Altman plot analyzing the mean difference between AHI levels
from ApneaLink Air and PSG. Clustering occurred at the lower end of mean AHI scores because
the majority of the participants had low OSA severity. Of the mean scores, 91% (n=68) fell
within the limits of agreement (± 2 SD) and 9% (n=7) outside of the limits of agreement. The
single sample t-test of differences, with a test value of zero, showed no significant differences [t
(74) = .18, p = .86]. The regression analysis showed that differences were not predictable by the
means as the regression coefficient was non-significant (B=-.06, p = .51). These analyses show
there was no significant difference and no proportional bias between AHI mean scores from
ApneaLink and PSG, supporting agreement.
In summary, the STOP Bang had the highest sensitivity while the ESS had the lowest.
The ESS had the highest specificity and reliability levels while the STOP Bang had the lowest.
Some questions on the Berlin may be difficult to answer for people who sleep alone. The
ApneaLink Air had the highest PPV. However, when the AHI was ≥ 30, the PPV was
unacceptable. AHI levels from the ApneaLink Air and STOP Bang were most highly correlated
with AHI levels from PSG. The ApneaLink Air had the strongest psychometric properties of all
OSA screening measures. No difference in mean AHI levels was shown using Bland-Altman
testing.
Discussion
This study’s purpose was to identify the psychometric properties of three self-report OSA
screening measures (Berlin, Epworth Sleepiness Scale, STOP Bang) and an objective PSM
(ApneaLink Air) compared to AHI levels from PSG. The desired outcome was to identify the
most reliable and valid screening measure(s) in patients referred to a sleep clinic. The major
finding was that the ApneaLink Air most consistently predicted AHI levels indicating the
presence of OSA. A limitation of ApneaLink Air was the low sensitivity levels at AHI ≥ 30. A
second major finding was that none of the self-report measures had entirely acceptable
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psychometric properties to be used independently for OSA screening. The psychometric
properties of the STOP Bang support it as the preferred self-report screening measure.
Regarding internal consistency reliability, the ESS had high levels but the Berlin and
STOP Bang had low levels. Since our data were cross-sectional, stability over time was not
measured. The stability is best supported by its ability to reproduce the same results at different
time-periods.
Validity testing was completed between the OSA screening measures and AHI levels
from PSG. Concurrent validity testing showed a significant but moderate correlation between
AHI levels from the ApneaLink Air and PSG; Bland-Altman testing showed there was no
significant difference in mean AHI scores from ApneaLink Air and PSG. Convergent validity
testing showed a significant but weak correlation between the Berlin and STOP Bang. The STOP
Bang and AHI levels from the ApneaLink Air were the most proficient at determining who
did/did not have OSA when compared to AHI ≥ 15 from PSG.
The ApneaLink Air had the highest level of sensitivity at AHI ≥ 5 and was the lowest at
AHI ≥ 30. This is concerning because 40% of persons with severe OSA were not identified as
having the sleep disorder using the device. Specificity levels were lowest at AHI ≥ 5 but were
high at moderate and severe OSA levels; this indicates that the ApneaLink Air was not proficient
at ruling out OSA at low levels of severity. Several other studies reported higher levels of
sensitivity and specificity across all ranges of OSA severity than found in this study using
ApneaLink PSM (H. Chen et al., 2009; Fredheim et al., 2014; Senchak et al., 2012). This study’s
results may have been affected by the automatic data scoring of the PSM compared to manual
scoring used in prior studies.
The Berlin has been tested in different outpatient populations and has documented
inconsistent sensitivity and specificity results compared to PSG. Some studies have found higher
sensitivity compared to specificity level (El-Sayed, 2012) but others have reported opposite
results (Best, Fitzpatrick, Milev, Bowie, & Jokic, 2013; Chung et al., 2008a; Geiger-Brown et al.,

106
PSYCHOMETRIC PROPERTIES
2013; Netzer et al., 1999). Both Netzer et al. (1999) and El-Sayed (2012) reported high levels of
PPV (97%, 87%) for the questionnaire but Chung et al. (2008b) found the measure had lower
PPV levels (51%) compared to NPV (78%). In this study, the Berlin had acceptable sensitivity
levels but values were lower when compared to the STOP Bang. The measure produced
unacceptable levels of specificity and inconsistent PPV and NPV. Overall, the measure performed
inconsistently which could have been impacted by the amount of missing data from Category 1,
questions two, three, and four.
The ESS has shown consistently low levels of sensitivity but higher levels of specificity
when compared with other OSA screening measures (El-Sayed, 2012; Faria, da Costa, & Rufino,
2015; Silva et al., 2011). This study is unique in finding an inverse relationship between PPV and
NPV in all of the OSA screening measures when compared to mild, moderate, and severe OSA.
This finding may have been influenced by the positive skewness of the AHI levels from PSG.
Using a screening measure with high levels of specificity, such as the ESS, allows for accurate
identification of patients who do not have the disease. The ESS had the highest specificity levels
at AHI ≥ 5, which means that 13% of patients who had moderate to severe OSA at AHI levels ≥
15 and ≥ 30 were not identified. This leads one to ask if the strength of the specificity outweighs
the weakness of missed OSA diagnoses.
The STOP Bang has shown consistently high levels of sensitivity and low levels of
specificity when compared to PSG across many psychometric studies regardless of patient
population (Abrishami et al., 2010; Boynton, Vahabzadeh, Hammoud, Ruzicka, & Chervin, 2013;
Chung, 2011; Chung et al., 2012; El-Sayed, 2012; Farney, Walker, Farney, Snow, & Walker,
2011; B. Kim, Lee, Chung, Kim, & Lee, 2015; Nagappa et al., 2015; Pereira et al., 2013; Silva et
al., 2011). The measures PPV and NPV have shown to be inconsistent between studies (Chung et
al., 2008a; Chung et al., 2008b; El-Sayed, 2012). The high levels of sensitivity in this study can
be explained by the scoring criteria of the measure; three positive scores indicate a positive screen
and need for further evaluation. Using a screening measure with high sensitivity but low
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specificity, such as the STOP Bang, can be useful when the test detects a disease that is serious
but treatable. Therefore, the STOP Bang identified a high number of participants with the disease
but at the cost of false positives.
The findings from this study are most similar to those of Pereira et al. (2013). Canadian
sleep clinic patients were studied and completed OSA screening measures (Berlin, STOP Bang,
and Sleep Apnea Clinical Score [SACS]) and level III PSM (MediByte). The diagnostic utility of
the tools were compared to laboratory PSG. The STOP Bang and Berlin were found to have the
highest sensitivity levels in all severities of OSA. Although Periera et al. reported PSM findings
as a RDI, the monitors used in both studies had very similar sensitivity levels at mild, moderate,
and severe OSA level. This study and Periera et al (2013) reported poor probability that the PSM
would detect an AHI ≥ 30. Collop et al. (2007) stated that false negative rates may be as high as
17% in PSM studies. This could be influenced by scoring methods used by researchers or
evidence of diagnostic limitations of the PSM. The calculation of total recording time rather than
total sleep time could also affect results (Nickerson et al., 2015).
This study has several strengths in its design. First, a sample size of N=170 was
calculated for the sample to have sufficient number of patients both with and without OSA and to
be representative of the general population. This assumed that approximately 24-34 participants
out of 170 would have a negative PSG. Second, this study compared three self-report and one
objective screening measure to PSG and variety of validity tests. This expands the knowledge of
validity testing of the OSA screening measures and adds to the current state of the science in this
area. Lastly, the results of this study can be generalized to other sleep clinic populations due to
the variety of settings patients were diagnosed in (home testing and three different sleep
laboratories).
It is important to acknowledge the limitations of this study. The participants were
recruited from a convenience sample at a Midwestern sleep clinic. The patients were referred
from their primary care provider or from other health care specialties but our data did not
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originate from a community based random sample. Another limitation of this study is the single
night use of the ApneaLink Air and the use of automatic scoring technique. Some data were
missing due to participant ineligibility, equipment failure, or inadequate wear time of the monitor.
Implications for Research
The AASM released a call in 2016 for volunteers to serve on a new OSA Assessment
Tools Task Force that will evaluate screening, assessment, and evaluation of current measures.
The task force will determine if measures used currently are reliable and effective at detecting
OSA in undiagnosed persons as well as make recommendations regarding the development of
new tools. The development of this committee encourages researchers to conduct more validation
testing of OSA screening measures in order to determine which tool has the best predictability
(American Academy of Sleep Medicine, 2016).
There are no current guidelines for OSA screening in outpatient settings. This is due in
part by inconsistent reports of sensitivity, specificity, PPV, and NPV of current OSA screening
measures. Further development of screening measures needs to include studying clinical variables
that make patients high risk for OSA (Epstein et al., 2009; Miller & Berger, 2016). Continued
improvement in technology will assist in more accurate identification of AHI levels and reduce
health care costs.
Implications for Practice
Health care providers need increased education on the importance screening and
assessment for OSA and encouragement to refer at-risk patients to sleep specialists for further
evaluation. Many patients who are diagnosed with OSA have already developed hypertension,
coronary artery disease, a stroke or have reduced left ventricular stroke volume. Early OSA
screening and assessment may reduce the likelihood of developing these comorbid conditions.
Screening measures are not ready to be used independently in a clinical setting. Therefore,
clinicians need to integrate assessment for OSA risk factors into their practice, such as evaluation
of patient’s comorbid cardiovascular and respiratory conditions, BMI, conducting a Mallampati
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score, and measuring a neck circumference. In addition, evaluating daytime sleepiness and
functioning levels are clinically relevant (Epstein et al., 2009; Miller & Berger, 2016).
To help guide the referral process to sleep specialists, sleep screening and assessment
can be followed by the use of a PSM. As evidenced in this study, PSM have been shown to be
effective in both screening and diagnosing OSA in specific patient populations. However, only
53% of participants qualified for PSM per AASM guidelines because of comorbid conditions
(Collop et al., 2007). Patients who are at risk for OSA need to be identified early in their disease
trajectory, prior to development of cardiovascular disease. The use of PSM can assist clinicians in
deciding which patients need to be referred to sleep specialists for OSA diagnosis. Patients who
have AHI levels from PSM ≥ 5 and < 15 need an assessment of daytime sleepiness. If patients
report excessive daytime sleepiness, a referral to a sleep specialist is necessary. Sleep specialists
are trained to manually interpret PSM data and can determine if results are accurate for OSA
diagnosis or if laboratory sleep testing is needed.
In conclusion, this study demonstrated that the STOP Bang questionnaire was the
preferred self-report OSA screening measure as it had the highest level of sensitivity. The ESS
was found to be the least psychometrically desirable. A positive screen on the STOP Bang
warrants assessment for OSA. If a patient qualifies, further screening with a PSM is indicated.
The ApneaLink Air had the most consistent ability to predict the presence of OSA but at the
expense of low sensitivity levels at AHI ≥ 30, indicating some patients with severe OSA would
have a missed diagnosis. PSM need to be used to guide the referral process from primary or
specialty care to sleep specialist. Earlier screening and detection of OSA will reduce the
development of cardiovascular conditions as well as all-cause mortality in adult patients.
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Figure 1: Conceptual Framework of the Relationship between Obstructive Sleep Apnea and
Cardiovascular Risk Factors Adapted From Kohli, Balachandran, & Malhotra
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Figure 2: Bland-Altman Plot Examining the Difference Between ApneaLink Air and PSG AHI Levels
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Table 1
Validity Testing
Criterion Validity
Predictive

The degree to which the OSA screening measures predict PSG AHI levels ≥ 15 (sensitivity,
specificity, positive predictive value, negative predictive value).

Concurrent

Correlating +/- screens on OSA measures scores to the AHI levels from laboratory PSG.
Construct Validity

Convergent

Correlating each measure’s +/- scores against the other OSA screening measures.

Known groups

Comparing each measure’s +/- screen to patients who did/did not have PSG AHI ≥ 15
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Table 2
Number of Positive OSA Screening Measures and PSG (N=170)
Berlin
(N=170)
n=143 (84%)

ESS
(n=168)
n= 37 (22%)

STOP Bang
(N=170)
n= 149 (88%)

ApneaLink Air
(n=87)
n=38 (44%)

PSG
(n=142)
n=65 (46%)
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Table 3
Predictive Validity Testing of OSA Screening Measures Compared to AHI Levels from PSG

ESS

Berlin
(N=170)

Measure

(n=168)

Cut-point

5

15

30

5

15

30

Sensitivity

88.89%

92.31%

90.32%

17.92%

20.63%

31.03%

Specificity

20.59%

18.18%

14.41%

88.24%

87.01%

87.39%

PPV

78.05%

48.78%

22.76%

82.61%

56.52%

39.13%

NPV

36.84%

73.68%

84.21%

25.64%

57.26%

82.91%

Measure

STOP Bang

ApneaLink

(N=170)

(n=83)

Cut-point

5

15

30

5

15

30

Sensitivity

94.44%

95.38%

96.77%

81.97%

78.95%

60.00%

Specificity

20.59%

12.99%

57.14%

86.49%

87.27%

PPV

79.07%

48.06%

23.26%

89.29%

85.71%

63.16%

NPV

53.85%

76.92%

92.31%

42.11%

80.00%

85.71%

10.81%

Berlin Questionnaire (Berlin); Epworth Sleepiness Scale (ESS); negative predictive value (NPV); positive predictive
value (PPV)
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Table 4
Known Groups, Concurrenta ,and Convergentb Validity Testing of OSA Screening Measures Compared to AHI Levels ≥ 15 (PSG)
Berlinb

ESSb

STOP-Bangb

ApneaLink Airb

PSGa

(n=170)

(n=168)

(n=170)

(n=87)

(n=142)

.154

.103

.145

.656**

-.121

-.060

.103

.196

.145

Concurrent/Convergent
PSG
Epworth

-.022

STOP Bang

.375**

-.121

.196

-.060

.196

-.022

.375**

.196

(χ2 3.346,

[t(138) = 1.46,

[t(140) = 3.40 ,

[t(58.45) =5.12,

p=0.067)c

p = .146]d

p = .001]d

p = <.001]d

ApneaLink Air
Berlin

Known Groups

Berlin Questionnaire (Berlin); Epworth Sleepiness Scale (ESS); polysomnogram (PSG)
** Correlation is significant at the 0.01 level (2-tailed).
a. Concurrent validity
b. Convergent validity
Chi-squared

.656**
.154
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Chapter IV.B. Analysis of Demographic, Clinical, and Biomarker Characteristics to
Determine Predictors of Apnea Hypopnea Index from Polysomnography in Midwestern
Sleep Clinic Patients
Dissertation Aim #2
The second aim for this dissertation study was to examine if selected demographic (age,
gender), clinical (diabetes, coronary artery disease, hyperlipidemia, myocardial infarction, stroke,
lung disease, smoking history, alcohol intake), and biomarker (blood pressure, heart rate, body
mass index (BMI), neck circumference, Mallampati score) variables predicted apnea hypopnea
index (AHI) from polysomnography (PSG).
Methods
Research Design
The design is a descriptive, prospective, cross-sectional study. The study was approved
by the University Institutional Review Board.
Sample/Setting
A convenience sample of adults (n=173) were invited and (n=170) were recruited. All
patients were being evaluated for obstructive sleep apnea (OSA) were recruited from a
Midwestern sleep clinic.
Chapter IV. A. Methods
Please see Chapter IV.A. for inclusion/exclusion criteria, informed consent, and
procedures.
Data Analysis
An estimate of 15-20% of PSG results are negative at Nebraska Pulmonary Specialties,
LLC for patients who undergo testing. A power analysis determined that a sample size of N=170
was a sufficient number of patients both with and without OSA and to be representative of the
population. This calculation assumed that approximately 24-34 participants out of 170 would
have a negative PSG result. For the regression analysis, n= 130 participants were included in the
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model. A maximum of 15 variables could have been included in the model if all correlated with
the outcome variable at p<.20. There were 15 demographic, clinical, and biomarker
characteristics. Therefore, a multiple regression model with 15 predictors and 130 participants
would provide 80% power to detect an effect size of f2 = .15, which is a medium effect size. The
planned sample size provided sufficient power to detect the effects of interest for this analysis.
First, data were entered into a secured Excel spreadsheet and rigorous procedures were
followed for data entry and editing. Data were cleaned and checked for outliers and missing data;
no outliers were removed. Descriptive statistics were performed on the sample of participants.
Next, Spearman’s correlational analyses were conducted; demographic (age, gender), clinical
(diabetes, coronary artery disease, hyperlipidemia, myocardial infarction, stroke, lung disease,
smoking history, alcohol history), and biomarker (blood pressure, heart rate, body mass index,
neck circumference, Mallampati score) variables were compared to determine their relationship
with AHI levels from PSG. Then, assumptions of multiple regression analysis (linearity,
homoscedasity, normality, and multicollinearity) were assessed. Bivariate scatterplots were used
to assess linearity and homoscedasity. Normality was evaluated by a) histograms to assess normal
distributions and b) skewness and kurtosis values. Skewness was assessed by examining the
symmetry of the distribution (positive or negative). The outcome variable was positively skewed,
indicating an abnormal distribution of data, and a log transformation of AHI levels (PSG) was
performed. Transformation of the AHI level scores (PSG) reduced the impact of the outliers. The
transformation of the variables normalized distribution of the AHI levels (PSG).
Potential covariates associated with AHI levels from PSG were examined for inclusion in
the multiple regression model. Prior to entering the variables into the model, correlational
analyses also were conducted between the predictors. Multiple regression analyses were used to
test a model of predictors of log AHI levels from PSG in participants (gender, comorbid health
conditions, smoking history, current tobacco use, alcohol use/amount, systolic and diastolic blood
pressure, heart rate, body mass index, neck circumference, and Mallampati score). Baseline
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variables that correlated with log AHI levels from PSG, at a significance level of P<.20, were
included in the model following a model-building strategy outlined by Hosmer and Lemeshow
(Hosmer & Lemeshow, 2000).
Variables that met the Homser and Lemeshow (2000) criteria and that were not highly
inter-correlated were entered into the multiple regression model. Using the model respecification
technique, age, diabetes mellitus, coronary artery disease, heart attack, stroke, current or past
tobacco use, alcohol use, diastolic blood pressure, heart rate, and Mallampati score were deleted
from the model (p > .05). Interactions between variables were then tested.
Descriptive statistics and multiple regression analysis were performed using IBM SPSS
Statistical Software, Version 23.
Results
This cross-sectional descriptive study took place in a sleep clinic and recruited patients
who were referred for sleep evaluation (n=170). The sample consisted of approximately half
males and half females. The means and standard deviations of clinical predictors were analyzed
(Table 1). On average, the participants were middle aged, obese, and pre-hypertensive. The
majority of patients reported using alcohol at least once a week. The most commonly selfreported co-morbid conditions were hyperlipidemia, lung disease and diabetes mellitus type II
(Table 2).
Multi-collinearity was assessed for and confounding factors, correlations, and potential
interactions were explored. Systolic and diastolic blood pressures were highly correlated with
each other (ρ=0.464). Diastolic blood pressure was deleted from the model because it had a
multicollinearity effect with systolic blood pressure. A slightly higher correlation was found
between systolic blood pressure and AHI levels from PSG (Table 3). Interactions were tested
between diastolic blood pressure and other variables and one was found with lung disease (Figure
1). If participants had lung disease, diastolic blood pressure did not predict OSA; however; if lung
disease was not present, diastolic blood pressure had a positive relationship with PSG. The
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Spearman’s correlation between diastolic blood pressure and PSG was not significant for those
with lung disease (ρ =-.071, p=.788, N=17) but for those without lung disease, there was a
significant correlation (ρ =.32, p=.001, N=113).
Interactions in the model were tested between gender and other variables (high
cholesterol, BMI, neck circumference, systolic blood pressure) (Table 4) and between systolic
blood pressure and other variables (high cholesterol, BMI, neck circumference, and lung disease)
(Table 5). In Table 4, there was a significant amount of variance accounted for by the variables in
the model (F=3.07, p=.002, adjusted R2=.138, R2=.205) with 20.5% of the variability of the
response variable accounted for by the predictors. Table 5 also supports a significant amount of
variance accounted for by variables in the model (F=2.89, p=.003, adjusted R2=.128, R2=.196).
No interactions occurred between gender or systolic blood pressure and other variables, meaning
that the effects of the variables on AHI levels from PSG did not vary depending on gender or
systolic pressure.
Of the 130 participants in the final regression model, 69 (53.1%) had an AHI < 15 and 61
(46.9%) had an AHI ≥15. The final model (Table 6) included gender, high cholesterol, lung
disease, systolic blood pressure, body mass index, and neck circumference (n=130); the model
predicted a significant level of variance in the continuous AHI levels by the variables in the
model (F =4.57, p<.001, R2=0.183, adjusted R2=0.143). The significant predictors in the model
included lung disease, systolic blood pressure, and body mass index. Systolic blood pressure and
BMI independently predicted AHI levels from PSG. Lung disease was a negative predicator for
AHI levels from PSG; therefore, persons with lung disease were less likely to have elevated AHI
levels from PSG.
Discussion
This study found that participants BMI, systolic blood pressure, and lack of lung disease
diagnosis were predictors for AHI levels ≥ 15 from PSG. The demographic, clinical, and
biomarker variables that did not predict AHI levels from PSG were age, gender, diabetes,

129
coronary artery disease, hyperlipidemia, myocardial infarction, stroke, smoking history, alcohol
intake, diastolic blood pressure, heart rate, neck circumference, and Mallampati Score. To our
knowledge, this is the first study to compare this combination of variables to AHI levels from
PSG.
BMI was shown to be a significant predictor for OSA and the relationship has previously
been studied. Rogers et al. (2015) investigated OSA predictors among African American
participants with metabolic syndrome (n=1,035). African American participants were at greater
risk for OSA relative to other adults in developed countries; obesity was found to be the strongest
independent predictor for OSA (OR=1.59, p <.001). Natsios et al.(2015) performed a
retrospective cohort study using a university database (N=1501) to determine predictors of
laboratory diagnosis of OSA for development of hypertension. BMI was found to be an accurate
predictor of hypertension in patients with OSA (p<.001). Kendzerska et al. (2014) conducted a
systematic review of the prognostic value of clinical and PSG characteristics of OSA for adverse
long-term outcomes of untreated OSA in adult patients. OSA was found to be associated with allcause and adverse cardiac outcomes (15 of 26 studies), including BMI (3 of 21 studies) and
hypertension (5 of 21 studies).
Systolic blood pressure was shown to be a significant predictor of OSA. Other studies
have confirmed the relationship between these two health conditions. Pedrosa et al. (2011)
conducted a cross-sectional study (N=125) that found OSA was the most common condition
(64%) associated with resistant hypertension. Pedrosa et al. (2013), studied the effect on blood
pressure with the use of continuous positive airway pressure (CPAP) to treat OSA in patients with
resistant hypertension (N=243). Findings were that the treatment of OSA with CPAP significantly
reduced daytime systolic blood pressure levels (p<.05). Haas et al.(2005) studied the association
between systolic and diastolic hypertension in relation to OSA. Findings supported that OSA was
associated with systolic and diastolic hypertension (AHI 15 to 29.9, OR=2.38; AHI ≥30,
OR=2.24) in participants less than 60 years old.
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The finding that the absence of lung disease was a significant predictor for OSA was
unique to this study. Most studies report a positive relationship between the presence of lung
disease and OSA. Zidan, Dabbis, and Gharraf (2015) assessed the prevalence of OSA in a group
of asthmatics (n=30) and controls (n=12). A regression analysis revealed that higher BMI
(p=0.03), gastroesophageal reflux disease (p=.034), and asthma severity (FEV1%) (p<.001) were
significant independent predictors for the development of OSA. Furthermore, the presence of
OSA was significantly associated with worse asthma control (p<.001). In a similar experimental
study, Greenberg-Dotan et. al. (2014) aimed to determine whether there is increased prevalence
of obstructive lung diseases in patients with OSA (N=1,497) when compared to a control group
(n=1,489). The study found that chronic obstructive pulmonary disease (COPD) (p<0.0001),
asthma (p<0.0001), and COPD with asthma (p<0.0001) were more prevalent in patients with
OSA across all AHI severities, compared to controls. One reason this study’s results differ from
prior studies may due to the small sample of participants recruited with lung disease (n=17).
Interpretation of the final model deserves further discussion due to its unique findings. In
Table 6, the F-test was highly significant, thus we can assume that there is a relationship between
the variables in the model and the outcome variable. R2, also known as the coefficient of multiple
determination, is a statistical measure of how close the data are to the fitted regression line and
provides an estimate of strength of the relationship between the model and the response variable
(Pagano, Gauvreau, & Pagano, 2000). In Table 6, R2= .183 and adjusted R2=.143, therefore
18.3% of variability of the response variable was accounted for by the predictors; however, the
model was overall significant which shows that BMI, systolic blood pressure, and absence of lung
disease are still associated with log AHI levels from PSG. This model can be subjectively
considered significant because it is reasonable to assume that an individual’s BMI, systolic blood
pressure, and absence of lung disease can be affected by many other health conditions besides
OSA; however, because the model was shown to be significant, the relationship between the
comorbid conditions and OSA deserves further investigation.
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This study had several strengths. All participants (N=170) completed the demographics
and health history questionnaire. Participants were given adequate time and support to complete
demographic questionnaires in private and were given adequate chances to ask questions. Also,
the sample consisted of persons with chronic comorbid conditions.
A limitation of the study was that lung disease was measured via self-report from
participants and was not validated using health records; this applies to all comorbid health
conditions and demographic variables obtained. Also, chronic disease severity was not assessed,
measured, or recorded. Only subjects who completed demographic, clinical, and biomarker
variables, and had AHI levels from PSG were included in the model (N=130).
Chapter 5 includes conclusions and implications for future research and practice for this
aim.

132
References
Greenberg-Dotan, S., Reuveni, H., Tal, A., Oksenberg, A., Cohen, A., Shaya, F. T., . . . Scharf, S.
M. (2014). Increased prevalence of obstructive lung disease in patients with obstructive
sleep apnea. Sleep and Breathing, 18(1), 69-75.

Haas, D. C., Foster, G. L., Nieto, F. J., Redline, S., Resnick, H. E., Robbins, J. A., . . . Pickering,
T. G. (2005). Age-dependent associations between sleep-disordered breathing and
hypertension: importance of discriminating between systolic/diastolic hypertension and
isolated systolic hypertension in the Sleep Heart Health Study. Circulation, 111(5), 614-621.
doi:111/5/614 [pii]

Hosmer, D. W., & Lemeshow, S. (2000). Introduction to the logistic regression model. Applied
Logistic Regression, Second Edition, , 1-30.

Kendzerska, T., Gershon, A. S., Hawker, G., Leung, R. S., & Tomlinson, G. (2014). Obstructive
sleep apnea and risk of cardiovascular events and all-cause mortality: A decade-long
historical cohort study. PLoS Medicine, 11(2), e1001599.

Natsios, G., Pastaka, C., Vavougios, G., Zarogiannis, S. G., Tsolaki, V., Dimoulis, A., . . .
Gourgoulianis, K. I. (2015). Age, Body Mass Index, and Daytime and Nocturnal Hypoxia as
Predictors of Hypertension in Patients With Obstructive Sleep Apnea. The Journal of
Clinical Hypertension,

Pagano, M., Gauvreau, K., & Pagano, M. (2000). Principles of biostatistics Duxbury Pacific
Grove, CA:.

133
Pedrosa, R. P., Drager, L. F., de Paula, L. K., Amaro, A. C., Bortolotto, L. A., & Lorenzi-Filho,
G. (2013). Effects of OSA treatment on BP in patients with resistant hypertension: a
randomized trial. CHEST Journal, 144(5), 1487-1494.

Pedrosa, R. P., Drager, L. F., Gonzaga, C. C., Sousa, M. G., de Paula, L. K., Amaro, A. C., . . .
Lorenzi-Filho, G. (2011). Obstructive sleep apnea: the most common secondary cause of
hypertension associated with resistant hypertension. Hypertension, 58(5), 811-817.
doi:10.1161/HYPERTENSIONAHA.111.179788 [doi]

Rogers, A., Ravenell, J., Donat, M., Sexias, A., Ogedegbe, C., McFarlane, S., & Jean-Louis, G.
(2015). Predictors of Obstructive Sleep Apnea Risk among Blacks with Metabolic
Syndrome. Journal of Obesity and Overweight, 1(1)

Zidan, M., Daabis, R., & Gharraf, H. (2015). Overlap of obstructive sleep apnea and bronchial
asthma: Effect on asthma control. Egyptian Journal of Chest Diseases and Tuberculosis,
64(2), 425-430.

134
Figure 1: PSG AHI Diastolic Blood Pressure and Lung Disease Interaction

DBP, Diastolic blood pressure
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Table 1
Mean and Standard Deviation of Participants’ (N=170) Clinical Health
Predictors
Clinical predictors

Mean ± SD

Range

Gender

(88M, 82F)

NA

Age

54.5 ± 15 years

20.4-89.5

Body mass index

34.8 ± 7.6 kg/m2

20.2-65.1

Mallampati score

2.7 ± 1.1

1-4

neck circumference

16 ± 2.1 inches

12-23.5

heart rate

93 ± 18.4

41-137

systolic blood pressure

124 ± 15

94-190

diastolic blood pressure

73± 10

32-99

BMI: 18.5, Underweight; 18.5-24.9, Healthy weight; 25.0-29.9, Overweight; 30.0 or > Obese
Blood systolic blood pressure (mmHg): < 120, normal; 120-139, prehypertension; 140-159, stage 1
hypertension; 160-180, stage 2 hypertension; 180 or >, hypertensive crisis
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Table 2
Number of Participants’ Co-morbid Conditions (n=170)
Co-morbid conditions

N

Lung disease

25

Diabetes mellitus

25

Coronary artery disease

16

High cholesterol

71

Heart attack

12

Hypertension

80

Stroke

5

Current tobacco use

17

Current alcohol use

115

Note: individuals could report one or more medical conditions
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Table 3
Correlational analyses between clinical variables and AHI levels from PSG (n=96-142)

AHI levels per Polysomnography
Correlation
Coefficient
Age

Sig. (2-tailed)

N

.065

.443

142

Gender (0-male, 1-female)

-.210*

.012

142

Diabetes mellitus

-.040

.635

142

Coronary artery disease

-.014

.870

142

High cholesterol

.110

.194

142

Heart attack

.065

.439

142

Stroke

-.052

.539

142

Lung disease

-.132

.132

132

Current tobacco use

-.001

.989

142

Previous smoking history

.055

.532

132

Current or Previous Smoker

.007

.935

142

Alcohol use

.078

.354

142

Amount of alcohol use

.051

.623

96

Systolic Blood Pressure

.256**

.002

140

Diastolic blood pressure

.232**

.006

140

Heart rate

.056

.514

140

BMI

.173*

.041

140

Neck circumference

.302**

.000

141

Mallampati Score

-.029

.740

132

*. Correlation is significant at the 0.05 level (2-tailed).
**. Correlation is significant at the 0.01 level (2-tailed).
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Table 4
Interactions Tested Between Gender and High Cholesterol, BMI, Neck Circumference,
and Systolic Blood Pressure (n=130)
Sum of

DF

Squares
Corrected Model

Mean

F

p

Partial Eta Squared

Square

32.844

10

3.284

3.068

.002

.205

Intercept

.276

1

.276

.258

.613

.002

Gender

.355

1

.355

.332

.566

.003

High cholesterol

1.341

1

1.341

1.253

.265

.010

Lung disease

5.797

1

5.797

5.416

.022

.044

Systolic blood pressure

2.123

1

2.123

1.984

.162

.016

Body mass index

7.612

1

7.612

7.112

.009

.056

Neck circumference

1.325

1

1.325

1.238

.268

.010

Gender*High

.390

1

.390

.365

.547

.003

3.113

1

3.113

2.908

.091

.024

1.549

1

1.549

1.447

.231

.012

.138

1

.138

.129

.720

.001

Cholesterol
Gender*Body Mass
Index
Gender*Neck
Circumference
Gender*Systolic Blood
Pressure
R2 = .205, adjusted R2 = .138
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Table 5
Interactions Tested Between Systolic Blood Pressure and High Cholesterol, BMI, Neck
Circumference, and Lung disease (n=130)
Sum of

DF

Squares
Corrected Model

Mean

F

p

Square

Partial Eta
Squared

31.344

10

3.134

2.894

.003

.196

Intercept

.535

1

.535

.494

.483

.004

Gender

3.388

1

3.388

3.128

.080

.026

High cholesterol

.008

1

.008

.007

.933

.000

Lung disease

.351

1

.351

.324

.570

.003

Systolic blood pressure

.200

1

.200

.185

.668

.002

Body mass index

.294

1

.294

.271

.603

.002

Neck circumference

.948

1

.948

.876

.351

.007

High Cholesterol* Systolic

.035

1

.035

.032

.858

.000

.063

1

.063

.058

.810

.000

.974

1

.974

.899

.345

.007

.937

1

.937

.865

.354

.007

Blood Pressure
Systolic Blood Pressure *
Body Mass Index
Systolic Blood Pressure*
Neck circumference
Lung disease*
Systolic blood pressure
R2 = .196, adjusted R2 = .128
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Table 6
Final Model of Multiple Regression with Respecification Analysis for
Variables Predicting Continuous AHI Levels from PSG (n=130)
b

SE (b)

Β

t

p

Gender

-.491

.269

-.220

-1.826

.070

Body mass index

.040

.019

.245

2.162

.033*

Systolic blood

.013

.006

.187

2.107

.037*

Neck circumference

-.005

.070

-.009

-.068

.946

Lung disease

-.662

.275

-.201

-2.406

.018*

High cholesterol

.164

.185

.073

.886

.377

pressure

R2 = .183, adjusted R2=.143, F = 4.579, p <.001
a. Dependent Variable: Log (PSG)
b. Gender: male, 0; female, 1
*Significant at .05 level.
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Chapter V: Conclusions, Discussion, and Implications for Research and Practice
This dissertation study was developed from the progression of knowledge focusing on the
current state of screening, assessment, and diagnosis of obstructive sleep apnea (OSA). Three
manuscripts included in this document are the result of the learning process that occurred
throughout the PhD program with the dissertation serving as the culmination of the doctoral
processes. The following paragraphs are a summary of knowledge development presented in
Chapters 1-4.B. followed by implications for future research, application to clinical practice, and
the author’s next steps in scholarship.
Chapter I: Introduction
Chapter 1 provided an introduction to the background and significance of the dissertation
study. The theoretical background and conceptual framework for the study were provided.
Definitions for major concepts (obstructive sleep apnea (OSA), screening, assessment, diagnosis)
were discussed. A discussion of reliability and validity was provided. The most commonly used
OSA screening measures (the Berlin Questionnaire (Berlin), Epworth Sleepiness Scale (ESS),
and the STOP Bang) were addressed in terms of types of questions, scoring, and limitations of the
tools. The description of OSA assessment and diagnosis was discussed. Lastly, an introduction to
the dissertation documents was presented.
Chapter II: Screening and Assessment for OSA in Primary Care
Sleep disorders are common in primary care patients but are rarely self-reported and go
unaddressed by primary health providers. This state of the science publication is an integrative
review aimed at evaluating current evidence regarding the screening and assessment for
obstructive sleep apnea (OSA) in primary care settings. This publication also includes a
discussion of OSA screening measures and the published psychometric properties of each one.
This is the first publication to discuss the current state of the science of screening and assessment
for OSA in primary care (Miller & Berger, 2016).
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Specific journal articles that were included in the literature review were based on the
following criteria: (a) published in the English language; (b) participants studied in primary care
setting/internal medicine; (c) providers practicing in primary care/internal medicine; (d) included
an OSA screening process; (e) compared OSA screening tools; and (f) used OSA assessment
criteria. Studies were excluded if: (a) conducted in any setting other than primary care/internal
medicine; (b) focused on sleep disorders other than OSA; (c) discussed long-term management of
OSA in primary care settings; (d) focused on management of OSA patients by sleep physicians;
and (e) used pediatric participants. After implementing the exclusion criteria, 17 articles met
criteria for this integrative literature review.
OSA screening measures were developed to aid health providers in quickly screening for
OSA in variety of health care settings (Abrishami et al., 2010; Ramachandran & Josephs, 2009;
Silva et al., 2011). As previously discussed, self-report screening measures are intended to
identify the patients that are in need of further assessment and possible referral to sleep
specialists. The screening measures with extensive validation studies that were discussed in the
review were the Berlin Questionnaire (Netzer et al., 1999), the Epworth Sleepiness Scale (ESS)
(Johns, 1991), and STOP Bang (Chung et al., 2008a).
Studies that met the inclusion criteria were 14 non-experimental and three experimental
designs. The results of the integrative literature review support that OSA is associated with
exacerbation of comorbid conditions and increased risk for morbidity and mortality.
Methodological testing of the OSA screening measures is necessary in primary care. There is lack
of consensus in the role that primary care providers can perform in screening, assessing, and
referring patients to sleep specialists for OSA. The findings from the review confirm that the
current practice model of screening and assessment for OSA in primary care is fragmented and
ineffective.
Chapter III: Methodological Strategies in Using Portable Sleep Monitoring in Research
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OSA in adults has been increasing in prevalence over the last two decades, which is
attributed in part to the obesity epidemic (Kendzerska et al., 2014; Peppard et al., 2013; Qaseem
et al., 2014). Because of the increase in OSA prevalence, sleep laboratory and diagnostic
polysomnogram (PSG) services are in high demand. Use of portable sleep monitors (PSM) has
increased in popularity due to technological improvements and accessibility. American Academy
of Sleep Medicine (AASM) established clinical guidelines that state the diagnosis of OSA needs
to occur with a comprehensive sleep evaluation and with Level III monitors with at least four
channels (Collop et al., 2007). PSM allow patients and clinicians a less expensive diagnostic
option for OSA in outpatient and home settings with satisfactory positive predicative value (PPV)
when compared to PSG
There are two purposes of the focused review on the methodological strategies when
using PSM in research. The first purpose was to synthesize the literature on use of level III PSM
in adult patients, in terms of: (a) sampling; (b) instrumentation issues; (c) clinical variables; (d)
data processing; and (e) patient acceptability. The second purpose was to identify methodological
strategies to use to standardize PSM information in research reports. This is the first known
focused review that presents suggestions for adoption when using PSM in research. Articles were
retrieved from 2000 to 2016 (n=371). Most articles were excluded (n=337) because Level III
PSM were not used. After implementing inclusion/exclusion criteria, 33 articles were included in
the focused review.
The research articles were inconsistent in reporting strategies. The authors identified five
criteria to examine. Samples of most studies included sleep participants who had OSA or were
suspected of having OSA (n=20). The most commonly reported instrumentation issue was device
malfunction. Scoring practices of the PSM data were discussed in the majority of the articles
(n=19). Almost all studies reported clinical variables (n=30). Several different PSM (n=14) were
used. Few studies (n=6) reported information on patient acceptability.
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Ten suggestions were made for adoption when using PSM in research. The body of
knowledge regarding PSM in research is growing rapidly. Future studies need to address the
methodological challenges and adopt the ten suggestions to promote consistency of reports and
advance knowledge.
Chapter IV.A.: Psychometric Properties of OSA Screening Measures in Patient Referred to
a Sleep Clinic; Aim 1 of Dissertation Study
Repetitive obstructive breathing events are caused by increased volume in upper airway
structures (Peppard et al., 2009) and result in intermittent hypoxia, activation of oxygen free
radicals, and an oxidative stress response. The long-term effects are development of co-morbid
vascular comorbid conditions (Aaronson et al., 2015; Heffner et al., 2012; Kohli et al., 2011;
Lipford et al., 2015; Yumino et al., 2013). Despite the evidence, OSA screening measures are not
used consistently in primary care or specialty clinics to guide the patient referral process.
An AASM task force is focusing on improving detection and categorization of OSA
symptoms and severity to promote screening, assessment, and diagnosis of the disorder (Aurora
et al., 2015). More psychometric testing of OSA screening measures was needed to determine
how well they predicted OSA in outpatient populations. The purpose of this methodological study
was evaluate the psychometric properties of three self-report OSA screening measures (Berlin,
ESS, STOP Bang) and an objective PSM (ApneaLink Air) compared to AHI levels (≥5, ≥ 15, and
≥ 30) from PSG in patients referred to a sleep clinic.
Patients referred to a sleep clinic (n=170) were enrolled in this study. The majority
completed all self-report screening measures (n=168). Only about half met criteria for home sleep
testing per AASM guidelines (n=91), however some were invalid due to insufficient data (n=8)
and equipment failure (n=2). Most participants completed physician ordered PSG testing (n=142).
The number of participants with complete data was 73.
Reliability testing was completed on the self-report screening measures. The ESS had
high Cronbach’s alpha levels, however, the Berlin and STOP Bang had very low Kudar-
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Richardson (KR-20) levels. Validity testing was completed between the OSA screening measures
and AHI levels from PSG. The STOP Bang and ApneaLink Air AHI levels were best at
predicting participants who did/did not have OSA compared to AHI ≥ 15 from PSG.
Findings were that the STOP Bang had the highest sensitivity of the self-report measures
while the ESS had the lowest; however, the ESS had the highest specificity. The Berlin produced
the second highest sensitivity levels. The ApneaLink Air AHI levels had the highest PPV. It is
important to note that not one self-report OSA screening measure has the psychometric properties
to be implemented on a standardized basis. However, sleep screening and assessment can be
followed by the use of a PSM; patients can then be referred to a sleep specialists when indicated.
Chapter IV.B.: Analysis of Demographic, Clinical, and Biomarker Characteristics to
Determine Predictors of Apnea Hypopnea Index from Polysomnography in Midwestern
Sleep Clinic Patients
This manuscript focuses on Aim 2, to examine if selected demographic (age, gender),
clinical (diabetes, coronary artery disease, hyperlipidemia, myocardial infarction, stroke, lung
disease, smoking history, alcohol intake), and biomarker (blood pressure, heart rate, body mass
index (BMI), neck circumference, Mallampati score) variables predicted apnea hypopnea index
(AHI) from PSG. To our knowledge, this is the first study to compare these combinations of
variables to AHI levels from PSG.
The sample (N=170) consisted of approximately half males and half females. The
majority of the participants consumed alcohol, had pre-hypertension, and hyperlipidemia.
Multi-collinearity was assessed and confounding factors, correlations, and potential
interactions were explored. Systolic and diastolic blood pressures were highly correlated with
each other therefore diastolic blood pressure was deleted from the model because it had a
multicollinearity effect. Interactions in the model were tested between gender and other variables
(high cholesterol, BMI, neck circumference, systolic blood pressure) and between systolic blood
pressure and other variables (high cholesterol, BMI, neck circumference, and lung disease). No
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interactions occurred between gender or systolic blood pressure and other variables, meaning that
the effects of the variables on AHI levels from PSG did not vary depending on gender or systolic
pressure. Participants who completed the pertinent demographic, clinical, and biomarker
variables, and had AHI levels from PSG, were included in the model (N=130).
The final model included gender, high cholesterol, lung disease, systolic blood pressure,
BMI, and neck circumference. The entire model predicted a significant level of variance in the
outcome by the variables in the model (F =4.573, p<.001, R2=.183, adjusted R2=.143). This study
found that participants BMI, systolic blood pressure, and lack of lung disease diagnosis were
independent predictors for AHI levels from PSG. Systolic blood pressure and BMI independently
predicted AHI levels from PSG. Lung disease was a negative predicator for AHI levels from
PSG; therefore, persons with lung disease were less likely to have OSA.
A strength of this study was that all participants completed the demographics and health
history questionnaire. A limitation of the study was that lung disease was measured via self-report
from participants and was not validated against health records; this applies to all comorbid health
conditions and demographic variables obtained.
Implications for Research
An AASM task force recently released quality measures for the care of adult patients
with OSA as well to improve detection and categorization of OSA symptoms and severity
(Aurora et al., 2015). AASM then released a call for volunteers to serve on a new OSA
Assessment Tools Task Force that will evaluate screening, assessment, and evaluation of current
measures. The task force will determine if measures used currently are reliable and effective at
detecting OSA in undiagnosed persons. The goals of this task force are three fold: (a) evaluate
current OSA screening measures pre and post continuous positive airway pressure titration to see
if they are reliable and effective, (b) develop a resource to inform members of existing measures,
and (c) recommend whether the AASM needs to develop additional screening measures and
mechanisms for completing this task (American Academy of Sleep Medicine, 2016). The
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development of this committee emphasizes the need for researchers to collaborate and conduct
validation testing of OSA screening measures. One timely implication is to submit a rigorous
manuscript to a high impact journal describing results of Aim 1 (Chapter IV.A.). A second timely
implication is to contact AASM task force members to express interest in future collaborations
that address these three goals.
Further research is needed to determine the psychometric properties of the STOP Bang
and appropriate use of PSM in outpatient settings. The findings from this study support further
research of the STOP Bang in primary care and specialty settings because its ability to be quickly
scored, acceptable reading level, and high levels of sensitivity. However, the STOP Bang has
shown high false positive rates for OSA. The use of Level III PSM has been studied primarily in
sleep laboratory settings and needs more validation testing in outpatient settings
Potential future studies will now be presented that are appropriate for this author’s career
stage. The first study is planned as a sub analysis using data collected from for this dissertation
study. Because the STOP Bang was shown to have high false positive rates with a score ≥ 3, the
analysis would compare a score ≥ 5 to Level III PSM apnea hypopnea index (AHI), respiratory
distress index (RDI), and oxygen desaturation index (ODI). These measures would then be
psychometrically compared to PSG AHI, RDI, and ODI data to further test predicative,
convergent, and concurrent validity. The results from the secondary analysis would test higher
STOP Bang cut-off scores against data from PSM and PSG testing in hopes to improve the
psychometrics of the measure.
To build on results of the sub analysis, a pilot study will take place in a primary care
and/or specialty setting. Patients with hypertension, BMI ≥ 35, and/or atrial fibrillation will be
screened for study eligibility that includes meeting AASM criteria for PSM testing. After
participant enrollment, a chart review will be completed to track co-morbid conditions,
medications, and vital signs. The clinic nurse will interview and gather data to complete and score
the STOP Bang and ESS, to assess for daytime sleepiness. Although the ESS has proven to be
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psychometrically inadequate for OSA screening, it is still a valuable measure for daytime
sleepiness. Participants will then complete two-nights of home PSM testing. STOP Bang scores ≥
5 and ESS total scores will be compared to AHI, RDI, and ODI from manually scored PSM data.
Providers would be made aware of participants’ STOP Bang, ESS, and PSM scores after testing
were completed.
Participants who were referred to sleep specialists will be followed through completion of
PSG. Data from STOP Bang ≥ 5, ESS, and manually scored PSM will be psychometrically
compared to physician ordered PSG results (AHI, RDI, ODI). A chart review will be conducted
on all participants who were not referred to a sleep specialist. The research team will conduct a
six-month follow-up to collect data on OSA diagnosis, treatment, health status and vital signs.
The longitudinal design of this study will allow researchers to follow patients who are at high-risk
for OSA through his/her treatment plan, initiated in a primary care or specialty setting. This pilot
study would be the first to test the OSA screening measures in this manner.
Implications for Practice
Screening and assessment for OSA needs to become a priority in primary care and
specialty settings. Health care providers need education on the importance of early screening,
assessment, and diagnosis of OSA and how early detection may reduce the development of co
morbid conditions (Bailes et al., 2009; Collop & Shafazand, 2013). In this study, BMI, systolic
blood pressure, and absence of lung disease were predictors of OSA. The first two co-morbid
conditions are in congruence with other studies. Many of the participants had chronic cardiac and
respiratory conditions that could possibly be reduced in severity with OSA treatment. While
research continues, a three-step process has been identified to improve the screening, assessment,
and referral process.
The first step emphasizes the importance of the clinic nurse identifying patients at highrisk for OSA in primary care settings. While obtaining the patient’s health history and changes in
medications, nurses would ask about signs and symptoms (snoring, witnessed apneas, nocturnal
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gasping or choking) and check the medical record for certain co-morbid conditions associated
with OSA (BMI > 35, congestive heart failure, atrial fibrillation, hypertension, type II diabetes)
(Miller & Berger, 2016). If the patients states that he/she has a sign or symptom or co-morbid
condition(s) making them high-risk for OSA, the nurse would administer a screening measure
with high levels of sensitivity, such as the STOP Bang (Chung et al., 2008a). The measure would
then be scored and patients with a positive OSA screen (≥ 5) would be flagged. The ESS would
be administered to measure daytime sleepiness levels. A trained health care provider could then
conduct a clinical assessment.
The second step includes an assessment conducted by a health care provider. The
assessment for OSA includes an examination of cardiovascular and respiratory systems including
visual inspection of the oral-naso-pharynx (Epstein et al., 2009). If the provider suspects the
presence of OSA, the patient would be evaluated for possible use of PSM.
The third step involves OSA evaluation with PSM. Patients who are appropriate for PSM
are outlined in the AASM Clinical Guidelines (Collop et al., 2007). If the patient is suspected of
having OSA and had a co-morbid condition that excluded him/her from PSM, a referral to a sleep
specialist must be provided. In patients who receive PSM in primary care or specialty settings,
results from PSM may be automatically scored by the primary care provider or specialty
clinician. If the results of the PSM indicate AHI levels ≥ 15, the patient should be referred a sleep
specialist for further evaluation. From this point, the sleep specialist can interpret the PSM data
and decide whether treatment can be prescribed from the study or if laboratory PSG testing is
warranted. If AHI levels were < 15 and the patient is not experiencing daytime sleepiness
symptoms, the clinician should encourage weight and blood pressure management. These patients
should be flagged for re-evaluation for OSA in 6 months.
AASM suggests that treatment modalities for OSA should not be prescribed by primary
care or specialty providers because a comprehensive sleep evaluation is needed. Only sleep
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specialists should prescribe OSA treatment methodologies from AHI levels from PSM as they
have been trained to analyze the data manually (Collop et al., 2007).
In conclusion, further testing of the STOP Bang is necessary in primary care and
specialty settings. There is not one OSA screening measure that can be widely implemented
across clinical settings without clinical assessment, but the STOP Bang has shown to have the
highest levels of sensitivity. More education is needed in primary care and specialty clinics. PSM
can aide in the referral process to sleep specialists but are not without flaws, such as equipment
failure and misplacement of sensors. More PSM research is needed to further establish reliability
and validity testing in outpatient settings. This three-step process for screening, diagnosis, and
treatment of OSA is ready for testing in primary care and specialty settings.
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Appendix A

Berlin Questionnaire
Scoring Berlin questionnaire
Adapted from: from Netzer, et al., 1999. (Netzer NC, Stoohs RA, Netzer CM, Clark K,
Strohl KP.Using the Berlin Questionnaire to identify patients at risk for the sleep apnea
syndrome. Ann Intern Med. 1999 Oct 5;131(7):485-91).
The questionnaire consists of 3 categories related to the risk of having sleep apnea.
Patients can be classified into High-Risk or Low Risk based on their responses to the
individual items and their overall scores in the symptom categories.
Categories and scoring: Category
1: items 1, 2, 3, 4, 5. Item 1: if
‘Yes’, assign 1 point
Item 2: if ‘c’ or ‘d’ is the response, assign 1 point Item
3: if ‘a’ or ‘b’ is the response, assign 1 point Item 4:
if ‘a’ is the response, assign 1 point
Item 5: if ‘a’ or ‘b’ is the response, assign 2 points
Add points. Category 1 is positive if the total score is 2 or more points
Category 2: items 6, 7, 8 (item 9 should be noted separately). Item 6: if
‘a’ or ‘b’ is the response, assign 1 point
Item 7: if ‘a’ or ‘b’ is the response, assign 1 point
Item 8: if ‘a’ is the response, assign 1 point
Add points. Category 2 is positive if the total score is 2 or more points Category 3 is
positive if the answer to item 10 is ‘Yes’ OR if the BMI of the patient is greater
than 30kg/m2.
(BMI must be calculated. BMI is defined as weight (kg) divided by height (m) squared, i.e.,
kg/m2).
High-Risk: if there are 2 or more Categories where the score is positive
Low Risk: if there is only 1 or no Categories where the score is positive
Additional question: item 9 should be noted separately.
Berlin Questionnaire
Height (m)
Weight (kg)
Age
Male /
Female Please choose the correct response to each question
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CATEGORY 1
1. Do you snore?
_ a. Yes
_ b. No
_ c. Don’t know

CATEGORY 2
6. How often do you feel tired or
fatigued after your sleep?
_ a. Nearly every day
_ b. 3-4 times a week
_ c. 1-2 times a week
_ d. 1-2 times a month
_ e. Never or nearly never

If you snore:
2. Your snoring is:
_ a. Slightly louder than breathing
_ b. As loud as talking
_ c. Louder than talking
_ d. Very loud – can be heard in adjacent

rooms

7. During your waking time, do you
feel tired, fatigued or not up to par?
_ a. Nearly every day
_ b. 3-4 times a week
_ c. 1-2 times a week
_ d. 1-2 times a month
_ e. Never or nearly never

3. How often do you snore
_ a. Nearly every day
_ b. 3-4 times a week
_ c. 1-2 times a week
_ d. 1-2 times a month
_ e. Never or nearly never

4. Has your snoring ever bothered
other people?
_ a. Yes
_ b. No
_ c. Don’t Know

5. Has anyone noticed that you quit
breathing during your sleep?
_ a. Nearly every day
_ b. 3-4 times a week
_ c. 1-2 times a week
_ d. 1-2 times a month
_ e. Never or nearly never

8. Have you ever nodded off or fallen
asleep while driving a vehicle?
_ a. Yes
_ b. No

If yes:
9. How often does this occur?
_ a. Nearly every day
_ b. 3-4 times a week
_ c. 1-2 times a week
_ d. 1-2 times a month
_ e. Never or nearly never

CATEGORY 3
10. Do you have high blood pressure?
_ Yes
_ No
_ Don’t know
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The Epworth Sleepiness Scale
The Epworth Sleepiness Scale is widely used in the field of sleep medicine as a subjective measure of
apatient's sleepiness. The test is a list of eight situations in which you rate your tendency to become
sleepy on a scale of 0, no chance of dozing, to 3, high chance of dozing. When you finish the test, add
up the values of your responses. Your total score is based on a scale of 0 to 24. The scale estimates
whether you are experiencing excessive sleepiness that possibly requires medical attention.
How Sleepy Are You?
How likely are you to doze off or fall asleep in the following situations? You should rate your
chancesof dozing off, not just feeling tired. Even if you have not done some of these things recently
try to determine how they would have affected you. For each situation, decide whether or not you
would have:






No chance of dozing
=0
Slight chance of dozing
=1
Moderate chance of dozing
=2
High chance of dozing
=3
Write down the number corresponding to your choice in the right hand column. Total your score below.
Situation
Sitting and reading

Chance of Dozing

Watching TV
Sitting inactive in a public place (e.g., a theater ora
meeting)
As a passenger in a car for an hour without a
break
Lying down to rest in the afternoon when
circumstances permit
Sitting and talking to someone
Sitting quietly after a lunch without alcohol
In a car, while stopped for a few minutes in traffic

Total Score =
Analyze Your Score
0-7:It is unlikely that you are abnormally sleepy.
8-9:You have an average amount of daytime sleepiness.
10-15:You may be excessively sleepy depending on the situation. You may want
to consider seeking medical attention.
16-24:You are excessively sleepy and should consider seeking medical attention.
Reference: Johns MW. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep, 1991;
14(6):540
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STOP-Bang Questionnaire
Property of University Health Network, for further info: www.stopbang.ca
Modified from Chung F et al. Anesthesiology 2008; 108:812-21, Chung F et al Br J Anaesth 2012;
108:768–75, Chung F et al J Clin Sleep Med Sept 2014
Yes

Yes

Snoring?
No Do you Snore Loudly (loud enough to be heard through closed doors or your bed-partner
elbows you for snoring at night)?
Tired?
No Do you often feel Tired, Fatigued, or Sleepy during the daytime (such as falling asleep
during driving)?

Yes

No Observed?
Has anyone Observed you Stop Breathing or Choking/Gasping during your sleep?

Yes

No Pressure?
Do you have or are being treated for High Blood Pressure?

Yes

No
Body Mass Index more than 35 kg/m2?

Yes

No
Age older than 50 year old?

Yes

Neck size large? (Measured around Adams apple)
For male, is your shirt collar 17 inches/43 cm or larger?
No For female, is your shirt collar 16 inches/41 cm or larger?

Yes

No
Gender = Male?

